ARTICLE ARTICLE article A AR ART ARTI BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 0 0 0 0 1
Received 21 received R Re Rec Rece BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 0 0 0 0 1
Synthesis and synthesis S Sy Syn Synt BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
and 18 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 / 1 10 0 0 0 0 1
lorlatinib lorlatinib lorlatinib l lo lor lorl BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 2 0 0 0 0 1
Thomas Lee thomas T Th Tho Thom BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 ,,.,.,,,., 10 9 0 0 0 0 1
Dustin W. dustin D Du Dus Dust BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 .,.,.,,,, 9 10 0 0 0 0 1
Kevin Maresca kevin K Ke Kev Kevi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 ,.,,, 5 8 0 0 0 0 1
Lorlatinib (PF-06463922) lorlatinib L Lo Lor Lorl BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 3 (-)-- 5 8 0 0 0 0 1
receptor tyrosine receptor r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 -(), 4 8 0 0 0 0 1
physiologically related physiologically p ph phy phys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 (),/ 4 9 0 0 0 0 1
clinical trial clinical c cl cli clin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 -. 2 10 0 0 0 0 1
concentrations of concentrations c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 , 1 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 -. 2 8 0 0 0 0 1
prepare both prepare p pr pre prep BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 -- 2 9 0 0 0 0 1
whole-body dosimetry whole-body w wh who whol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 -().- 5 9 0 0 0 0 1
radiolabelling strategies radiolabelling r ra rad radi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 3 - 1 10 0 0 0 0 1
and an and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 -.-- 4 9 0 0 0 0 1
prepared with prepared p pr pre prep BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 . 1 9 0 0 0 0 1
PET imaging pet P PE PET PET BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 0 3 - 1 8 0 0 0 0 1
permeability. permeability. permeability. p pe per perm BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 3 . 1 1 0 0 0 0 1
DOI: 10.1038/ncomms15761 doi: D DO DOI DOI: BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 7 :./ 3 10 0 0 0 0 1
OPEN OPEN open O OP OPE OPEN BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 10 0 0 0 0 1
1 Massachusetts 1 1 1 1 1 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 7 ,,,,..,,, 9 9 0 1 0 0 1
New York new N Ne New New BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 ,.,,,,..,, 10 9 0 1 0 0 1
Research and research R Re Res Rese BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 7 ,,,,., 6 9 0 1 0 0 1
Drive, San drive, D Dr Dri Driv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 ,,,.:,,,,(...); 15 10 0 1 0 0 1
Waterhouse Imaging waterhouse W Wa Wat Wate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 7 ,,,,(...). 10 9 0 1 0 0 1
materials should materials m ma mat mate BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 ..(:.@..). 10 4 0 1 0 0 1
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 ::./../ 7 10 0 1 0 0 0
1 1 1 1 1 1 1 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 11 no 0 10 0 1 0 0 0
A A a A A A A BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 0 0 no 0 10 0 1 0 0 1
naplastic lymphoma naplastic n na nap napl BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 () 2 6 0 1 0 0 1
insulin receptor insulin i in ins insu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 7 0 1 0 0 1
primarily expressed primarily p pr pri prim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,. 2 7 0 1 0 0 1
a dozen a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 0 0 no 0 7 0 1 0 0 1
cancer types cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -, 2 9 0 1 0 0 1
and United and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 7 0 1 0 0 1
ALK inhibitors alk A AL ALK ALK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 -- 2 8 0 1 0 0 1
cancer patients. cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .(-)-, 6 8 0 1 0 0 1
small-molecule inhibitor small-molecule s sm sma smal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 8 0 1 0 0 1
c-ros oncogene c-ros c c- c-r c-ro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 -(), 4 7 0 1 0 0 1
physiologically related physiologically p ph phy phys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 8 0 1 0 0 1
available, ATP-competitive available, a av ava avai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,- 2 7 0 1 0 0 1
therapeutic potential therapeutic t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -, 2 7 0 1 0 0 1
and significantly and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 7 0 1 0 0 1
the first-generation-approved the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 --() 4 8 0 1 0 0 1
including the including i in inc incl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 /-/ 3 8 0 1 0 0 1
inhibitor, crizotinib inhibitor, i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ,(),- 5 8 0 1 0 0 1
and ALK/ROS1 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 /,,. 4 8 0 1 0 0 1
inhibitors (and inhibitors i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 () 2 8 0 1 0 0 1
to therapy, to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 8 0 1 0 0 1
domain of domain d do dom doma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 7 0 1 0 0 1
pharmacokinetic (PK) pharmacokinetic p ph pha phar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 () 2 7 0 1 0 0 1
not optimized not n no not not BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 7 0 1 0 0 1
metastases in metastases m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 -() 3 8 0 1 0 0 1
the brain the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 1 0 0 1
effectiveness, and effectiveness, e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,- 2 8 0 1 0 0 1
(BBB) penetration (bbb) ( (B (BB (BBB BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 () 2 8 0 1 0 0 1
pumps 11-13 pumps p pu pum pump BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -. 2 8 0 1 0 0 1
unmet clinical unmet u un unm unme BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 8 0 1 0 0 1
against TKI-resistant against a ag aga agai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -,-, 4 8 0 1 0 0 1
alectinib-and ceritinib-resistant alectinib-and a al ale alec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 -- 2 7 0 1 0 0 1
microtubule-associated protein-like microtubule-associated m mi mic micr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 --(-)- 6 7 0 1 0 0 1
mutant 14 mutant m mu mut muta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ./ 2 8 0 1 0 0 1
trial investigations trial t tr tri tria BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 (://.///) 9 9 0 1 0 0 1
in ROS1 in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 -,-. 4 7 0 1 0 0 1
Unfortunately, imaging unfortunately, U Un Unf Unfo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 7 0 1 0 0 1
associated signal associated a as ass asso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 1 0 0 1
potent and potent p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 1 0 0 1
neuroimaging 22-27 neuroimaging n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 -(). 4 7 0 1 0 0 1
This lack this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 1 0 0 1
challenges of challenges c ch cha chal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,- 2 8 0 1 0 0 1
density receptor density d de den dens BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 8 0 1 0 0 1
and competition and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 1 0 0 1
ATP. These atp. A AT ATP ATP. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 . 1 8 0 1 0 0 1
radiochemistry required radiochemistry r ra rad radi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 7 0 1 0 0 1
structurally complex structurally s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 7 0 1 0 0 1
radiotracer for radiotracer r ra rad radi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 8 0 1 0 0 1
ALK-targeted therapeutics alk-targeted A AL ALK ALK- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 - 1 8 0 1 0 0 1
engagement by engagement e en eng enga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 8 0 1 0 0 1
as well as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 8 0 1 0 0 1
understand the understand u un und unde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 8 0 1 0 0 1
effort has effort e ef eff effo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 7 0 1 0 0 1
crizotinib 28 crizotinib c cr cri criz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 , 1 8 0 1 0 0 1
develop a develop d de dev deve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ;, 2 8 0 1 0 0 1
evaluate the evaluate e ev eva eval BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 8 0 1 0 0 1
radiotracer would radiotracer r ra rad radi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 7 0 1 0 0 1
of ALK-drug of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 7 0 1 0 0 1
metastases. In metastases. m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 .,- 3 7 0 1 0 0 1
( 11 ( ( ( ( ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 0 (;,.)-(;,.)- 12 10 0 1 0 0 1
labelled isotopologues labelled l la lab labe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 1 0 0 1
biodistribution and biodistribution b bi bio biod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 [] 2 7 0 1 0 0 1
tumour-bearing rodents tumour-bearing t tu tum tumo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 --(). 5 7 0 1 0 0 1
Results Results results R Re Res Resu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 5 no 0 1 0 0 0 0 1
Precursor synthesis. precursor P Pr Pre Prec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 . 1 10 0 0 0 0 1
radiolabelling of radiolabelling r ra rad radi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 ,(()----,, 10 9 0 0 0 0 1
16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H À 16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2h 1 16 16- 16-t BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 5 ----,,,--,-() 13 8 0 1 0 0 1
pyrazolo[4,3 À pyrazolo[4,3 p py pyr pyra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 5 [,][,,]---- 11 9 0 1 0 0 1
nitrile (PF-06463922; nitrile n ni nit nitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 (-;()-),(()-()-; 16 8 0 1 0 0 1
Fig. 1) fig. F Fi Fig Fig. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 .). 3 8 0 1 0 0 1
Compounds (R)-2 compounds C Co Com Comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 ()-()- 6 8 0 1 0 0 1
for 11 for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 , 1 8 0 1 0 0 1
whereas compound whereas w wh whe wher BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ()- 3 8 0 1 0 0 1
an iodonium an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 5 -.()- 5 9 0 1 0 0 1
(R)-5 were (r)-5 ( (R (R) (R)- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 5 ()- 3 10 0 1 0 0 1
aromatic substitution aromatic a ar aro arom BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 -. 2 10 0 1 0 0 1
Synthesis of synthesis S Sy Syn Synt BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 (()-). 6 8 0 0 0 0 1
Compound (R)-2 compound C Co Com Comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 ()- 3 8 0 0 0 0 1
metabolite studies metabolite m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 no 0 10 0 0 0 0 1
with [ with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 [](.;.). 8 9 0 0 0 0 1
(R)-2 in (r)-2 ( (R (R) (R)- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 6 ()-, 4 9 0 0 0 0 1
amide nitrogen amide a am ami amid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 [];, 4 9 0 0 0 0 1
strategy would strategy s st str stra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 , 1 8 0 0 0 0 1
and carry and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 -/. 3 8 0 0 0 0 1
Attempting to attempting A At Att Atte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 --- 3 8 0 0 0 0 1
idine compound idine i id idi idin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 ()-,, 5 9 0 0 0 0 1
the tri-Boc-protected the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 --, 3 9 0 0 0 0 1
remove the remove r re rem remo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 . 1 9 0 0 0 0 1
results, and results, r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 ,, 2 9 0 0 0 0 1
approach to approach a ap app appr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 ()-., 5 9 0 0 0 0 1
a direct a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 0 6 , 1 9 0 0 0 0 1
although the although a al alt alth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 no 0 9 0 0 0 0 1
by protection by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 . 1 10 0 0 0 0 1
yield (o5%) yield y yi yie yiel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 () 2 7 0 0 0 0 1
attempted to attempted a at att atte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 ()-., 5 8 0 0 0 0 1
successful for successful s su suc succ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 ()-(.;.). 9 7 0 0 0 0 1
Synthesis of synthesis S Sy Syn Synt BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 []([]()-). 10 8 0 0 0 0 1
short half-life short s sh sho shor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 8 --, 3 9 0 0 0 0 1
[ 11 [ [ [ [ [ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 8 []()--- 7 8 0 0 0 0 1
tected precursor tected t te tec tect BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 8 ()-[]'' 7 10 0 0 0 0 1
(Fig. 2). (fig. ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 8 (.)., 5 10 0 0 0 0 1
out on out o ou out out BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 -() 3 8 0 0 0 0 1
prior to prior p pr pri prio BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 ,. 2 9 0 0 0 0 1
The 'Loop the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 ''- 3 8 0 0 0 0 1
11 C-methylation 11 1 11 11 11 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 8 -,( 3 10 0 0 0 0 1
cooling required) cooling c co coo cool BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 ), 2 8 0 0 0 0 1
adaptation to adaptation a ad ada adap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 . 1 9 0 0 0 0 1
of precursor of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 ()-[] 5 9 0 0 0 0 1
an HPLC an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 8 ()-() 5 8 0 0 0 0 1
N,N-dimethylformamide (DMF) n,n-dimethylformamide N N, N,N N,N- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 8 ,-(). 5 7 0 0 0 0 1
tetrabutylammonium hydroxide tetrabutylammonium t te tet tetr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 8 (,) 3 8 0 0 0 0 1
room temperature. room r ro roo room BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 ., 2 8 0 0 0 0 1
were eluted were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 no 0 7 0 0 0 0 1
uncorrected radiochemical uncorrected u un unc unco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 8 (). 3 8 0 0 0 0 1
Analysis of analysis A An Ana Anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 no 0 8 0 0 0 0 1
the major the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 no 0 9 0 0 0 0 1
the desired the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 , 1 8 0 0 0 0 1
precursor (R)-2, precursor p pr pre prec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 ()-,. 5 9 0 0 0 0 1
out that out o ou out out BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 no 0 9 0 0 0 0 1
the desired the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 ,[]()-, 7 9 0 0 0 0 1
salt [ salt s sa sal salt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 []()-.- 7 8 0 0 0 0 1
favourably at favourably f fa fav favo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 no 0 8 0 0 0 0 1
electron-releasing properties electron-releasing e el ele elec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 -, 2 8 0 0 0 0 1
to enhanced to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 . 1 9 0 0 0 0 1
challenge to challenge c ch cha chal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 []()- 5 8 0 0 0 0 1
with confidence with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 no 0 9 0 0 0 0 1
translation, we translation, t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 ,- 2 8 0 0 0 0 1
on a on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 -- 2 8 0 0 0 0 1
diBoc-protected amine diboc-protected d di diB diBo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 8 -. 2 8 0 0 0 0 1
ARTICLE ARTICLE article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 no 0 10 0 1 0 0 0
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 :./ 3 10 0 1 0 0 0
2 2 2 2 2 2 2 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 11 no 0 10 0 0 0 0 0
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 ::./../ 7 10 0 0 1 1 0
H H h H H H H BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
H H h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
N N n N N N N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
I I i I I I I BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
- - - - - - - BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 - 1 10 1 0 0 0 1
+ + + + + + + BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 4 1 0 0 0 1
H 3 h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 8 1 0 0 0 1
11 C 11 1 11 11 11 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 1 1 0 0 1
11 11 11 1 11 11 11 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 0 no 0 10 1 1 0 0 1
C C c C C C C BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 1 1 0 0 1
11 11 11 1 11 11 11 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
CH 3 ch C CH CH CH BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
F F f F F F F BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
F F f F F F F BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
F F f F F F F BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
a, b a, a a, a, a, BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 10 1 0 0 0 1
or or or o or or or BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 6 1 0 0 0 1
CH 3 ch C CH CH CH BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 1 no 0 10 1 0 0 0 1
CH 3 ch C CH CH CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 1 no 0 10 1 0 0 0 1
CH 3 ch C CH CH CH BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 1 no 0 10 1 0 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 1 no 0 10 1 0 0 0 1
H 3 h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 1 no 0 10 1 0 0 0 1
H 3 h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 1 no 0 10 1 0 0 0 1
NH 2 nh N NH NH NH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 1 no 0 8 1 0 0 0 1
NH 2 nh N NH NH NH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 1 no 0 8 1 0 0 0 1
NH 2 nh N NH NH NH BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 1 no 0 8 1 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 1 no 0 10 1 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 1 no 0 10 1 0 0 0 1
(R)-2 (R)-2 (r)-2 ( (R (R) (R)- BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 1 ()- 3 4 1 0 0 0 1
[ 11 [ [ [ [ [ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 1 []()- 5 10 1 0 0 0 1
[ 11 [ [ [ [ [ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 1 []()- 5 10 1 0 0 0 1
(R)-3 (R)-3 (r)-3 ( (R (R) (R)- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 1 ()- 3 4 1 1 0 0 1
[ 11 [ [ [ [ [ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 1 []()- 5 10 1 1 0 0 1
[ 11 [ [ [ [ [ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 1 []()- 5 10 1 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 no 0 10 1 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 no 0 10 1 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 no 0 10 1 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 no 0 10 1 0 0 0 1
H H h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 no 0 10 1 1 0 0 1
N N n N N N N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 no 0 10 1 1 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 no 0 10 1 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 no 0 10 1 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 no 0 10 1 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 no 0 10 1 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 no 0 4 1 1 0 0 1
H 3 h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 no 0 8 1 1 0 0 1
11 C 11 1 11 11 11 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 2 no 0 10 1 1 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 no 0 8 1 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 no 0 10 1 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 no 0 10 1 1 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 no 0 10 1 1 0 0 1
F F f F F F F BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 no 0 10 1 1 0 0 1
F F f F F F F BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 no 0 10 1 1 0 0 1
F F f F F F F BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 no 0 10 1 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 no 0 10 1 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 2 no 0 10 1 1 0 0 1
a, b, a, a a, a, a, BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 ,, 2 10 1 1 0 0 1
d, e, d, d d, d, d, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 2 ,, 2 10 1 1 0 0 1
CH 3 ch C CH CH CH BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 3 no 0 10 1 1 0 0 1
CH 3 ch C CH CH CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 3 no 0 10 1 1 0 0 1
CH 3 ch C CH CH CH BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 3 no 0 10 1 1 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 3 no 0 10 1 1 0 0 1
H 3 h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 3 no 0 10 1 1 0 0 1
H 3 h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 3 no 0 10 1 1 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 3 no 0 6 1 1 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 3 no 0 6 1 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 3 no 0 4 1 1 0 0 1
NH 2 nh N NH NH NH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 3 no 0 10 1 1 0 0 1
N N n N N N N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 3 no 0 4 1 1 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 3 no 0 8 1 1 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 3 no 0 8 1 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 3 no 0 10 1 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 3 no 0 10 1 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 3 no 0 10 1 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 3 no 0 10 1 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 3 no 0 10 1 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 3 no 0 10 1 1 0 0 1
Figure 2 figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 3 [].-()()-[] 11 9 1 1 0 0 1
confirmation of confirmation c co con conf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 ,[]()-.-() 10 9 1 1 0 0 1
simplified the simplified s si sim simp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 .:()(()-()-),.(), 17 9 1 1 0 0 1
anhydrous DMF; anhydrous a an anh anhy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 3 ;()[],'';()();().,,;()., 24 10 1 1 0 0 1
NaOAc, 6 naoac, N Na NaO NaOA BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 3 ,;(). 5 2 1 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 6 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 6 no 0 10 0 1 0 0 1
F F f F F F F BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 6 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 6 no 0 10 0 1 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 6 no 0 10 0 1 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 6 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 6 no 0 10 0 1 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 6 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 7 no 0 10 0 1 0 0 1
CH 3 ch C CH CH CH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 7 no 0 10 0 1 0 0 1
NH 2 nh N NH NH NH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 no 0 10 0 0 0 0 1
Lorlatinib (PF-06463922; lorlatinib L Lo Lor Lorl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 (-;()-)) 8 10 0 0 0 0 1
(R)-2 (R)-2 (r)-2 ( (R (R) (R)- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 ()- 3 8 0 0 0 0 1
(R )-3 (r ( (R (R (R BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 ()- 3 10 0 0 0 0 1
(R)-4 (R)-4 (r)-4 ( (R (R) (R)- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 ()- 3 8 1 0 0 0 1
(R )-5 (r ( (R (R (R BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 ()- 3 10 1 0 0 0 1
(R)-6 (R)-6 (r)-6 ( (R (R) (R)- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 ()- 3 8 1 0 0 0 1
11 11 11 1 11 11 11 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 7 no 0 10 0 0 0 0 1
C Precursors c C C C C BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 7 no 0 10 0 0 0 0 1
18 F 18 1 18 18 18 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 7 no 0 10 1 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 7 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 7 no 0 10 0 0 0 0 1
F F f F F F F BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 7 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 7 no 0 10 0 0 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 7 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
CH 3 ch C CH CH CH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
NH 2 nh N NH NH NH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
F F f F F F F BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
CH 3 ch C CH CH CH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
O 2 o O O O O BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
CH 3 ch C CH CH CH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
O 2 o O O O O BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
CH 3 ch C CH CH CH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
NH 2 nh N NH NH NH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
I I i I I I I BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 10 no 0 10 0 0 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 10 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 10 no 0 10 0 0 0 0 1
CH 3 ch C CH CH CH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 10 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 10 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 10 no 0 10 0 0 0 0 1
H H h H H H H BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 10 no 0 10 0 0 0 0 1
H H h H H H H BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 10 no 0 10 0 0 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 10 no 0 10 0 0 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 10 no 0 10 0 0 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 10 no 0 10 0 0 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 10 no 0 10 0 0 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 10 no 0 10 0 0 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 10 no 0 10 0 0 0 0 1
Figure 1 figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 10 .. 2 10 1 0 0 0 1
blue for blue b bl blu blue BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 10 []()[]().()-. 13 9 1 0 0 0 1
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 :./ 3 10 0 1 0 0 0
ARTICLE ARTICLE article A AR ART ARTI BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 no 0 10 0 1 0 0 0
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 ::./../ 7 10 1 1 0 0 0
3 3 3 3 3 3 3 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 11 no 0 10 1 1 0 0 0
In order in I In In In BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 0 no 0 8 1 1 0 0 1
favour selective favour f fa fav favo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 9 1 1 0 0 1
Boc-protected molecule, boc-protected B Bo Boc Boc- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 -,()-,- 7 9 1 1 0 0 1
labelling employing labelling l la lab labe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 []' 3 9 1 1 0 0 1
Method', followed method', M Me Met Meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ', 2 9 1 1 0 0 1
commercial radiofluorination commercial c co com comm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (; 2 8 1 1 0 0 1
Supplementary Fig. supplementary S Su Sup Supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 .).- 4 8 1 1 0 0 1
procedure (Fig. procedure p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (.),[]()- 9 10 1 1 0 0 1
easily separated easily e ea eas easi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ()-, 4 9 1 1 0 0 1
HPLC, and hplc, H HP HPL HPLC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 , 1 8 1 1 0 0 1
(Supplementary Fig. (supplementary ( (S (Su (Sup BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (.).[] 6 9 1 1 0 0 1
was pushed was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ()-, 4 8 1 1 0 0 1
DMF over dmf D DM DMF DMF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ., 2 9 1 1 0 0 1
and after and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 1 1 0 0 1
system for system s sy sys syst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 9 1 1 0 0 1
the chromatographic the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 1 1 0 0 1
[ 11 [ [ [ [ [ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 []()-()- 8 9 1 1 0 0 1
starting precursor starting s st sta star BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ()-., 5 8 1 1 0 0 1
[ 11 [ [ [ [ [ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 []()-, 6 8 1 1 0 0 1
groups were groups g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 () 2 9 1 1 0 0 1
5 min. 5 5 5 5 5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 0 ., 2 9 1 1 0 0 1
with NaOH with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ()(). 5 8 1 1 0 0 1
final product final f fi fin fina BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 () 2 9 1 1 0 0 1
reformulated in reformulated r re ref refo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 [] 2 9 1 1 0 0 1
([ 11 ([ ( ([ ([ ([ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ([]()-),(-) 11 9 1 1 0 0 1
end of end e en end end BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 () 2 8 1 1 0 0 1
3 Ci 3 3 3 3 3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 0 ,. 2 7 1 1 0 0 1
This work this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 1 1 0 0 1
two-step 11 two-step t tw two two- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 8 1 1 0 0 1
radiofluorination unit radiofluorination r ra rad radi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 8 1 1 0 0 1
modification that modification m mo mod modi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 1 1 0 0 1
GE TracerLab ge G GE GE GE BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 . 1 8 1 1 0 0 1
find applications find f fi fin find BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 9 1 1 0 0 1
two-step reactions two-step t tw two two- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -,. 3 3 1 1 0 0 1
In vivo in I In In In BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 4 []()-. 6 10 0 0 0 0 1
initially performed initially i in ini init BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 []()-. 6 10 0 0 0 0 1
rhesus macaques, rhesus r rh rhe rhes BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 , 1 9 1 1 0 0 1
intravenous injection intravenous i in int intr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 []()-, 6 9 1 1 0 0 1
previously reported previously p pr pre prev BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 8 1 1 0 0 1
non-radioactive molecule non-radioactive n no non non- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 -.- 3 8 1 1 0 0 1
revealed radioactivity revealed r re rev reve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 (.), 4 10 1 1 0 0 1
the latter the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 9 1 1 0 0 1
progressively shifted progressively p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ( 1 8 1 1 0 0 1
Figs 22 figs F Fi Fig Figs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 ).- 3 8 1 1 0 0 1
locally high locally l lo loc loca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 9 1 1 0 0 1
value (SUV) value v va val valu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ()(.); 6 8 1 1 0 0 1
maximum measured maximum m ma max maxi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 . 1 8 1 1 0 0 1
at B10 at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 . 1 9 1 1 0 0 1
uptake, followed uptake, u up upt upta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 , 1 8 1 1 0 0 1
NHPs (Fig. nhps N NH NHP NHPs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 4 (.). 4 8 1 1 0 0 1
but is but b bu but but BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 , 1 9 1 1 0 0 1
highest [ highest h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 [], 3 9 1 1 0 0 1
cortex and cortex c co cor cort BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ; 1 9 1 1 0 0 1
matter; and matter; m ma mat matt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ;. 2 7 1 1 0 0 1
It is it I It It It BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 8 1 1 0 0 1
uptake of uptake u up upt upta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 9 1 1 0 0 1
subcutaneous human subcutaneous s su sub subc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 (--) 4 7 1 1 0 0 1
xenografts and xenografts x xe xen xeno BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 - 1 8 1 1 0 0 1
with blocking with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ()., 4 9 1 1 0 0 1
initial results initial i in ini init BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 9 1 1 0 0 1
B30-60 min b30-60 B B3 B30 B30- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 -[]()-(.-./) 12 9 1 1 0 0 1
and co-injection and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 -()- 4 9 1 1 0 0 1
the tumour the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 (./) 4 8 1 1 0 0 1
course of course c co cou cour BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 . 1 2 1 1 0 0 1
The dosimetry the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 - 1 8 1 1 0 0 1
the injection the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 []()-.- 7 9 1 1 0 0 1
are generally are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 ,-. 3 9 1 1 0 0 1
Radioactivity levels radioactivity R Ra Rad Radi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 8 1 1 0 0 1
animals at animals a an ani anim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 . 1 8 1 1 0 0 1
With these with W Wi Wit With BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 ,., 3 9 1 1 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 . 1 8 1 1 0 0 1
(Supplementary Table (supplementary ( (S (Su (Sup BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 (). 3 8 1 1 0 0 1
are consistent are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 -. 2 8 1 1 0 0 1
Clinical translation clinical C Cl Cli Clin BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 10 1 1 0 0 1
10 10 10 1 10 10 10 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 9 no 0 7 1 1 0 0 1
2.5 2.5 2.5 2 2. 2.5 2.5 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 9 . 1 10 1 1 0 0 1
0.020 0.020 0.020 0 0. 0.0 0.02 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 9 . 1 10 1 1 0 0 1
Frontal cortex frontal F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
Thalamus Thalamus thalamus T Th Tha Thal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 no 0 6 0 0 0 0 1
Cerebellum Cerebellum cerebellum C Ce Cer Cere BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 no 0 7 0 0 0 0 1
White matter white W Wh Whi Whit BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 9 no 0 8 0 0 0 0 1
0.015 0.015 0.015 0 0. 0.0 0.01 BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 9 . 1 10 1 1 0 0 1
0.010 0.010 0.010 0 0. 0.0 0.01 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 9 . 1 10 1 1 0 0 1
0.005 0.005 0.005 0 0. 0.0 0.00 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 9 . 1 10 1 1 0 0 1
0.000 0.000 0.000 0 0. 0.0 0.00 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 9 . 1 10 1 1 0 0 1
2.5 2.5 2.5 2 2. 2.5 2.5 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 9 . 1 10 0 0 0 0 1
2.0 2.0 2.0 2 2. 2.0 2.0 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 9 . 1 10 1 1 0 0 1
1.5 1.5 1.5 1 1. 1.5 1.5 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 10 . 1 10 1 1 0 0 1
1.0 1.0 1.0 1 1. 1.0 1.0 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 10 . 1 10 1 1 0 0 1
0.5 0.5 0.5 0 0. 0.5 0.5 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 10 . 1 10 1 1 0 0 1
0.0 0.0 0.0 0 0. 0.0 0.0 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 10 . 1 10 1 1 0 0 1
0 0 0 0 0 0 0 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 10 no 0 5 1 1 0 0 1
c c c c c c c BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 1 10 no 0 10 0 0 0 0 1
b b b b b b b BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 1 10 no 0 10 1 1 0 0 1
a a a a a a a BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 1 10 no 0 10 1 1 0 0 1
30 30 30 3 30 30 30 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 10 no 0 2 1 1 0 0 1
60 60 60 6 60 60 60 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 10 no 0 2 1 1 0 0 1
Time (min) time T Ti Tim Time BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 10 () 2 10 1 1 0 0 1
90 90 90 9 90 90 90 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 10 no 0 7 1 1 0 0 1
120 120 120 1 12 120 120 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 10 no 0 10 1 1 0 0 1
0 0 0 0 0 0 0 BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 10 no 0 0 0 0 0 0 1
Whole body whole W Wh Who Whol BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 10 () 2 10 0 0 0 0 1
%I.D./g %I.D./g %i.d./g % %I %I. %I.D BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 10 ../ 3 10 1 1 0 0 1
Brain PET brain B Br Bra Brai BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 10 () 2 10 1 0 0 0 1
Regional uptake regional R Re Reg Regi BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 10 () 2 10 1 1 0 0 1
0 0 0 0 0 0 0 BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 10 no 0 10 1 1 0 0 1
Figure 3 figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 10 -[].[]()-. 10 10 1 1 0 0 1
(a) Maximum (a) ( (a (a) (a) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 10 ()- 3 9 1 1 0 0 1
radiotracer administration. radiotracer r ra rad radi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 10 .()- 4 9 1 1 0 0 1
injection. (c) injection. i in inj inje BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 .(),. 5 7 1 1 0 0 1
ARTICLE ARTICLE article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 no 0 10 1 1 0 0 0
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 :./ 3 10 1 1 0 0 0
4 4 4 4 4 4 4 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 11 no 0 10 0 0 0 0 0
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 ::./../ 7 10 0 0 1 0 0
submissions should submissions s su sub subm BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 10 0 1 0 0 1
studies are studies s st stu stud BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 4 0 1 0 0 1
Synthesis of synthesis S Sy Syn Synt BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 []. 3 9 0 0 0 0 1
half-life of half-life h ha hal half BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -- 2 9 0 0 0 0 1
and imaging and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -., 3 8 0 0 0 0 1
the ability the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 0 0 0 1
of an of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -, 2 9 0 0 0 0 1
and multicentre and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 8 0 0 0 0 1
can be can c ca can can BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .,-, 4 9 0 0 0 0 1
particularly since particularly p pa par part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
prepared. For prepared. p pr pre prep BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .- 2 8 0 0 0 0 1
needed for needed n ne nee need BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -(;.), 6 9 0 0 0 0 1
standard amidation standard s st sta stan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
investigated to investigated i in inv inve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 9 0 0 0 0 1
enantiopure starting enantiopure e en ena enan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ,- 2 9 0 0 0 0 1
late-stage chiral late-stage l la lat late BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -, 2 9 0 0 0 0 1
desired enantiomer. desired d de des desi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 2 0 0 0 0 1
Our current our O Ou Our Our BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 0 0 0 1
enough substrate enough e en eno enou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ;, 2 9 0 0 0 0 1
in order in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 0 , 1 9 0 0 0 0 1
a higher-yielding a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 1 0 -. 2 8 0 0 0 0 1
such as such s su suc such BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ()-,()-()- 10 8 0 0 0 0 1
success of success s su suc succ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 9 0 0 0 0 1
what point what w wh wha what BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 9 0 0 0 0 1
the stereochemistry the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ()- 3 8 0 0 0 0 1
macrocycles, we macrocycles, m ma mac macr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 , 1 9 0 0 0 0 1
scale to scale s sc sca scal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
decision being decision d de dec deci BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 0 0 0 1
more efficient more m mo mor more BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ., 2 10 0 0 0 0 1
arylation route arylation a ar ary aryl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
improvement in improvement i im imp impr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 9 0 0 0 0 1
as well as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (.). 4 8 0 0 0 0 1
Using the using U Us Usi Usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 ., 2 9 0 0 0 0 1
racemic 5 racemic r ra rac race BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 , 1 8 0 0 0 0 1
chiral supercritical chiral c ch chi chir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (). 3 9 0 0 0 0 1
the materials the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ()- 3 8 0 0 0 0 1
enabled the enabled e en ena enab BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ()-. 4 6 0 0 0 0 1
The harsh the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 7 0 0 0 0 1
both (R)-4 both b bo bot both BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ()-()- 6 8 0 0 0 0 1
macrocycle, in macrocycle, m ma mac macr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 , 1 9 0 0 0 0 1
nitrile moiety nitrile n ni nit nitr BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 ()., 4 9 0 0 0 0 1
18 F-labelling 18 1 18 18 18 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 4 -. 2 9 0 0 0 0 1
spirocyclic hypervalent spirocyclic s sp spi spir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 ()- 3 9 0 0 0 0 1
strategy, based strategy, s st str stra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 ,- 2 8 0 0 0 0 1
fluorides in fluorides f fl flu fluo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 ., 2 9 0 0 0 0 1
purified precursors purified p pu pur puri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 no 0 8 0 0 0 0 1
workup procedures. workup w wo wor work BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 . 1 8 0 0 0 0 1
regioselectivity and regioselectivity r re reg regi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 no 0 10 0 0 0 0 1
array of array a ar arr arra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 -() 3 8 0 0 0 0 1
suitable for suitable s su sui suit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 -. 2 8 0 0 0 0 1
methodology in methodology m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 ,()-, 5 9 0 0 0 0 1
were confident were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 no 0 8 0 0 0 0 1
enantiopure (R)-5. enantiopure e en ena enan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 ()-..,- 7 8 0 0 0 0 1
provides (R)-4, provides p pr pro prov BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 ()-,()- 7 9 0 0 0 0 1
dithionite. Diazotization/iodination dithionite. d di dit dith BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 ./ 2 9 0 0 0 0 1
the requisite the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 ()-. 4 5 0 0 0 0 1
The corresponding the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 4 ()- 3 8 0 0 0 0 1
general literature general g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 (.);, 5 9 0 0 0 0 1
the aryl the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 ()- 3 8 0 0 0 0 1
trimethylsilyl acetate trimethylsilyl t tr tri trim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 no 0 9 0 0 0 0 1
compound. A compound. c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 .,-[.]-, 8 8 0 0 0 0 1
9-dione was 9-dione 9 9- 9-d 9-di BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 - 1 8 0 0 0 0 1
the reaction the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 no 0 8 0 0 0 0 1
iododiacetoxy starting iododiacetoxy i io iod iodo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 ., 2 9 0 0 0 0 1
ylide (R)-13 ylide y yl yli ylid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 ()-. 4 5 0 0 0 0 1
Radiosynthesis of radiosynthesis R Ra Rad Radi BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 [].- 4 8 0 0 0 0 1
odenitration with odenitration o od ode oden BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 []([]) 6 9 0 0 0 0 1
the nitro the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 (-) 3 9 0 0 0 0 1
ranging from ranging r ra ran rang BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 ;,[]()- 7 9 0 0 0 0 1
not be not n no not not BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 . 1 9 0 0 0 0 1
then attempted then t th the then BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 ; 1 8 0 0 0 0 1
however, complete however, h ho how howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 , 1 8 0 0 0 0 1
the final the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 ( 1 8 0 0 0 0 1
Figs 16 figs F Fi Fig Figs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 ).()-()- 8 9 0 0 0 0 1
electron-rich aromatic electron-rich e el ele elec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 - 1 9 0 0 0 0 1
nucleophilic aromatic nucleophilic n nu nuc nucl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 no 0 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 -, 2 8 0 0 0 0 1
labelling with labelling l la lab labe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 -. 2 9 0 0 0 0 1
It is it I It It It BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 10 0 0 0 0 1
in our in i in in in BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 6 ., 2 9 0 0 0 0 1
O 2 o O O O O BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
OH OH oh O OH OH OH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 6 0 0 0 0 1
CH 3 ch C CH CH CH BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
Br Br br B Br Br Br BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
NH N nh N NH NH NH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
CH 3 ch C CH CH CH BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 7 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
+ + + + + + + BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 4 0 0 0 0 1
a a a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 2 8 no 0 4 0 0 0 0 1
b, c b, b b, b, b, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 , 1 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 1 0 0 1
O 2 o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 1 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 1 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 1 0 0 1
CH 3 ch C CH CH CH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 1 0 0 1
NH 2 nh N NH NH NH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 0 1 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 1 0 0 1
d, e d, d d, d, d, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 , 1 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 1 0 0 1
H 2 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 1 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
CH 3 ch C CH CH CH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
f f f f f f f BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
I I i I I I I BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
CH 3 ch C CH CH CH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
9 9 9 9 9 9 9 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 9 no 0 5 0 1 0 0 1
1 0 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
1 1 1 1 1 1 1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 1 0 0 1
O 2 o O O O O BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 0 0 0 1
CH 3 ch C CH CH CH BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 no 0 8 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 0 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 0 0 0 1
Br Br br B Br Br Br BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 no 0 10 0 0 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 no 0 10 0 0 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 0 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 0 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 3 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 4 0 0 0 0 1
CH 3 ch C CH CH CH BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 10 0 0 0 0 1
(R )-5 (r ( (R (R (R BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 ()- 3 8 0 1 0 0 1
(R )-12 (r ( (R (R (R BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 ()- 3 10 0 1 0 0 1
(R )-6 (r ( (R (R (R BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 ()- 3 8 0 1 0 0 1
Figure 4 figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 10 ()-()-.:().,(),,-, 18 9 0 1 0 0 1
room temperature room r ro roo room BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 10 (),,;(),(),,,-,,;()/,, 22 9 0 1 0 0 1
rt, 56 rt, r rt rt, rt, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 10 ,,,;()(),.,,,,;(),, 19 10 0 1 0 0 1
H 2 h H H H H BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 10 /(:),,,;(),,,,,. 16 6 0 1 0 0 1
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 :./ 3 10 0 1 0 0 0
ARTICLE ARTICLE article A AR ART ARTI BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 no 0 10 0 1 0 0 0
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 ::./../ 7 10 0 1 0 0 0
5 5 5 5 5 5 5 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 11 no 0 10 0 1 0 0 0
our iodonium our o ou our our BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -- 2 9 0 1 0 0 1
most effective most m mo mos most BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 0 1 0 0 1
(R)-1 (Fig. (r)-1 ( (R (R) (R)- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 ()-(.),, 8 9 0 1 0 0 1
starting [ starting s st sta star BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 []( 3 9 0 1 0 0 1
fluorodenitration 39 fluorodenitration f fl flu fluo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 ),. 3 9 0 1 0 0 1
We anticipate we W We We We BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 1 0 0 1
18 F-labelling 18 1 18 18 18 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 0 - 1 8 0 1 0 0 1
candidates 40 candidates c ca can cand BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 .[]()- 6 10 0 1 0 0 1
further investigations further f fu fur furt BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 4 0 1 0 0 1
Discussion Discussion discussion D Di Dis Disc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 1 0 0 0 0 1
Clinically useful clinically C Cl Cli Clin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 -- 2 9 0 0 0 0 1
the ROS1/ALK the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 /, 2 9 0 0 0 0 1
possibility for possibility p po pos poss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 - 1 9 0 0 0 0 1
and brain and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 .- 2 8 0 0 0 0 1
radiolabelling strategies radiolabelling r ra rad radi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 , 1 8 0 0 0 0 1
molecules were molecules m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
strategically placed strategically s st str stra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 .--- 4 9 0 0 0 0 1
18-labelled lorlatinib 18-labelled 1 18 18- 18-l BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 - 1 9 0 0 0 0 1
via a via v vi via via BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 --, 3 10 0 0 0 0 1
well as well w we wel well BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -. 2 9 0 0 0 0 1
The initial the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
[ 11 [ [ [ [ [ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 0 []. 3 8 0 0 0 0 1
with [ with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 [] 2 9 0 0 0 0 1
tumour models, tumour t tu tum tumo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,, 2 8 0 0 0 0 1
preclinical translation preclinical p pr pre prec BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 []. 3 6 0 0 0 0 1
Methods Methods methods M Me Met Meth BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 10 0 0 0 0 1
General chemistry general G Ge Gen Gene BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 . 1 8 0 0 0 0 1
reagents were reagents r re rea reag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 1 no 0 9 0 0 0 0 1
purification unless purification p pu pur puri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 .,-, 4 10 0 0 0 0 1
commercially available commercially c co com comm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 -. 2 9 0 0 0 0 1
positive pressure positive p po pos posi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 ,, 2 9 0 0 0 0 1
(unless otherwise (unless ( (u (un (unl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 1 (),,. 5 9 0 0 0 0 1
Analytical thin-layer analytical A An Ana Anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 -()- 4 9 0 0 0 0 1
Gel 60_F gel G Ge Gel Gel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 ((.) 4 9 0 0 0 0 1
ratios (v/v). ratios r ra rat rati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 (/). 4 9 0 0 0 0 1
One system one O On One One BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 . 1 9 0 0 0 0 1
was high-purity was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 ---. 4 9 0 0 0 0 1
Reactions were reactions R Re Rea Reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 8 0 0 0 0 1
consumption of consumption c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 ., 2 9 0 0 0 0 1
phosphomolybdic acid phosphomolybdic p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 1 .- 2 9 0 0 0 0 1
carried out carried c ca car carr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 . 1 9 0 0 0 0 1
determined by determined d de det dete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 .: 2 9 0 0 0 0 1
X-Bridge C18 x-bridge X X- X-B X-Br BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 1 -,.,,-/ 7 8 0 0 0 0 1
buffered with buffered b bu buf buff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 1 ./.,, 5 8 0 0 0 0 1
1.2 ml 1.2 1 1. 1.2 1.2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 .,(,). 6 6 0 0 0 0 1
Spectroscopy. Multi-NMR spectroscopy. S Sp Spe Spec BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 3 .-, 3 9 0 0 0 0 1
Bruker 400 bruker B Br Bru Bruk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 3 ,, 2 9 0 0 0 0 1
are given are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 (...). 6 10 0 0 0 0 1
were obtained were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 -(...), 7 9 0 0 0 0 1
using chloroform using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 (....)- 7 8 0 0 0 0 1
(2.50 p.p.m.), (2.50 ( (2 (2. (2.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 (....),. 8 10 0 0 0 0 1
following abbreviations: following f fo fol foll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 :,,,, 5 9 0 0 0 0 1
br ¼ br b br br br BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 3 ,,. 3 9 0 0 0 0 1
constants, when constants, c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 ,,(). 5 9 0 0 0 0 1
an Agilent an a an an an BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 3 ,. 2 9 0 0 0 0 1
spectrum data spectrum s sp spe spec BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 no 0 9 0 1 0 0 1
(LCMS) on (lcms) ( (L (LC (LCM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 4 () 2 9 0 1 0 0 1
(APCI) or (apci) ( (A (AP (APC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 4 ()(). 5 10 0 1 0 0 1
from neat from f fr fro from BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 -. 2 5 0 1 0 0 1
Synthesis of synthesis S Sy Syn Synt BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 [].()- 6 8 0 1 0 0 1
originally synthesized originally o or ori orig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 9 0 1 0 0 1
precursor for precursor p pr pre prec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 -[](.).- 8 10 0 1 0 0 1
Suzuki coupling suzuki S Su Suz Suzu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 3 4 ()-, 4 9 0 1 0 0 1
A as a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 3 4 -()-, 5 9 0 1 0 0 1
the precursor the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 .- 2 8 0 1 0 0 1
challenging step challenging c ch cha chal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 , 1 8 0 1 0 0 1
high dilution high h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 4 . 1 8 0 1 0 0 1
conformational preferences conformational c co con conf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 no 0 9 0 1 0 0 1
success of success s su suc succ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 , 1 9 0 1 0 0 1
EDCI-mediated ring edci-mediated E ED EDC EDCI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 4 -( 2 9 0 1 0 0 1
obtained in obtained o ob obt obta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 ()-, 4 9 0 1 0 0 1
methyl group methyl m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 ,- 2 9 0 1 0 0 1
the cyclization the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 9 0 1 0 0 1
amine). Other amine). a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 ).--, 5 9 0 1 0 0 1
presence of presence p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 /(/) 4 8 0 1 0 0 1
observed in observed o ob obs obse BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 ()-. 4 7 0 1 0 0 1
Methyl 2-[(1R)-1-{[2-amino-5-(3-{[bis(tert-butoxycarbonyl)amino]methyl}- methyl M Me Met Meth BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 -[()--[---(-[(-)]- 18 8 0 0 0 0 1
5-cyano-1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]oxy}ethyl]-4-fluorobenzoate 5-cyano-1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]oxy}ethyl]-4-fluorobenzoate 5-cyano-1-methyl-1h-pyrazol-4-yl)pyridin-3-yl]oxy}ethyl]-4-fluorobenzoate 5 5- 5-c 5-cy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 -------)--]]-- 14 8 0 0 0 0 1
(R)-17. To (r)-17. ( (R (R) (R)- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 ()-.-()--[(-----)- 18 8 0 0 0 0 1
y]ethyl}-4-fluorobenzoate (R)-15 y]ethyl}-4-fluorobenzoate y y] y]e y]et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 ]--()-(.,.),--[(--- 19 9 0 0 0 0 1
cyano-1-methyl-1H-pyrazol-3-yl)methyl]imidodicarbonate 16 cyano-1-methyl-1h-pyrazol-3-yl)methyl]imidodicarbonate c cy cya cyan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 ------)](, 10 7 0 0 0 0 1
1.22 mmol) 1.22 1 1. 1.2 1.22 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 .)(,.)() 8 8 0 0 0 0 1
cataCXium A catacxium c ca cat cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 (,.)()(,.). 11 8 0 0 0 0 1
reaction mixture reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 9 0 0 0 0 1
NaOH (12 naoh N Na NaO NaOH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 6 (,.). 5 9 0 0 0 0 1
resulting mixture resulting r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 10 0 0 0 0 1
to reflux to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 (/ 2 9 0 0 0 0 1
3:1). Upon 3:1). 3 3: 3:1 3:1) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 :)., 4 9 0 0 0 0 1
EtOAc (3 etoac E Et EtO EtOA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 6 (), 3 8 0 0 0 0 1
(2 Â (2 ( (2 (2 (2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 (),, 4 9 0 0 0 0 1
which was which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 8 0 0 0 0 1
petroleum ether/EtOAc petroleum p pe pet petr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 /(::)-[()--[--- 15 9 0 0 0 0 1
(3-{[bis(tert-butoxycarbonyl)amino]methyl}-5-cyano-1-methyl-1H-pyrazol-4-yl) (3-{[bis(tert-butoxycarbonyl)amino]methyl}-5-cyano-1-methyl-1H-pyrazol-4-yl) (3-{[bis(tert-butoxycarbonyl)amino]methyl}-5-cyano-1-methyl-1h-pyrazol-4-yl) ( (3 (3- (3-{ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 (-[(-)]--------) 16 9 0 0 0 0 1
pyridine-3-yl]oxy}ethyl]-4-fluorobenzoate (R)-17 pyridine-3-yl]oxy}ethyl]-4-fluorobenzoate p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 --]]--()-(,). 13 9 0 0 0 0 1
LCMS (APCI) lcms L LC LCM LCMS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 6 ()/.[]. 7 4 0 0 0 0 1
Methyl 2-[(1R)-1-({2-amino-5-[3-(aminomethyl)-5-cyano-1-methyl-1H-pyr- methyl M Me Met Meth BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 -[()--(---[-()------- 21 8 0 0 0 0 1
azol-4-yl]pyridin-3-yl}oxy)ethyl]-4-fluorobenzoate (R)-18. azol-4-yl]pyridin-3-yl}oxy)ethyl]-4-fluorobenzoate a az azo azol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 --]--)]--()-. 13 8 0 0 0 0 1
solution of solution s so sol solu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 ()-(,.)() 9 10 0 0 0 0 1
manner at manner m ma man mann BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 8 (,). 4 9 0 0 0 0 1
the addition the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 , 1 9 0 0 0 0 1
2 h 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 8 . 1 9 0 0 0 0 1
was concentrated was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 -[()--(--- 10 8 0 0 0 0 1
[3-(aminomethyl)-5-cyano-1-methyl-1H-pyrazol-4-yl]pyridin-3-yl}oxy)ethyl]-4- [3-(aminomethyl)-5-cyano-1-methyl-1H-pyrazol-4-yl]pyridin-3-yl}oxy)ethyl]-4- [3-(aminomethyl)-5-cyano-1-methyl-1h-pyrazol-4-yl]pyridin-3-yl}oxy)ethyl]-4- [ [3 [3- [3-( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 [-()--------]--)]-- 19 9 0 0 0 0 1
fluorobenzoate (R)-18, fluorobenzoate f fl flu fluo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 8 ()-, 4 9 0 0 0 0 1
purification. LCMS purification. p pu pur puri BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 .()/.[]. 8 5 0 0 0 0 1
2-[(1R)-1-({2-amino-5-[3-(aminomethyl)-5-cyano-1-methyl-1H-pyrazol-4- 2-[(1R)-1-({2-amino-5-[3-(aminomethyl)-5-cyano-1-methyl-1H-pyrazol-4- 2-[(1r)-1-({2-amino-5-[3-(aminomethyl)-5-cyano-1-methyl-1h-pyrazol-4- 2 2- 2-[ 2-[( BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 -[()--(---[-()-------- 22 8 0 0 0 0 1
yl]pyridin-3-yl}oxy)ethyl]-4-fluorobenzoic acid yl]pyridin-3-yl}oxy)ethyl]-4-fluorobenzoic y yl yl] yl]p BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 ]--)]--()-.()- 14 9 0 0 0 0 1
(B300 mg) (b300 ( (B (B3 (B30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 ()(.,.)() 9 9 0 0 0 0 1
°C °C °c ° °C °C °C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 no 0 0 0 0 0 0 1
for 36 for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 . 1 9 0 0 0 0 1
solvent was solvent s so sol solv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 ,. 2 10 0 0 0 0 1
HCl to hcl H HC HCl HCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 ., 2 8 0 0 0 0 1
and then and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 (). 3 9 0 0 0 0 1
dried over dried d dr dri drie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 -[()--(--- 10 9 0 0 0 0 1
[3-(aminomethyl)-5-cyano-1-methyl-1H-pyrazol-4-yl]pyridin-3-yl}oxy)ethyl]-4- [3-(aminomethyl)-5-cyano-1-methyl-1H-pyrazol-4-yl]pyridin-3-yl}oxy)ethyl]-4- [3-(aminomethyl)-5-cyano-1-methyl-1h-pyrazol-4-yl]pyridin-3-yl}oxy)ethyl]-4- [ [3 [3- [3-( BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 [-()--------]--)]-- 19 9 0 0 0 0 1
O O o O O O O BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 3 0 1 0 0 1
H 3 h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 3 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
I I i I I I I BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
O N o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
N N n N N N N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 3 0 1 0 0 1
N N n N N N N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 3 0 1 0 0 1
CH 3 ch C CH CH CH BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 8 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
O O o O O O O BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 3 0 1 0 0 1
H 3 h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 3 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
O N o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
18 F 18 1 18 18 18 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
N N n N N N N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 3 0 1 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 3 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
CH 3 ch C CH CH CH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
Boc Boc boc B Bo Boc Boc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
a, b a, a a, a, a, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 , 1 10 0 1 0 0 1
c, d c, c c, c, c, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 10 , 1 10 0 1 0 0 1
O O o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 3 0 1 0 0 1
H 3 h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 3 0 1 0 0 1
NH 2 nh N NH NH NH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
O N o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
18 F 18 1 18 18 18 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
H 3 h H H H H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
N N n N N N N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 3 0 1 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 3 0 1 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
CH 3 ch C CH CH CH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
(R )-13 (r ( (R (R (R BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 ()- 3 6 0 1 0 0 1
[ 18 [ [ [ [ [ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 []()- 5 10 0 1 0 0 1
[ 18 [ [ [ [ [ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 11 []()- 5 10 0 1 0 0 1
Figure 5 figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 11 []()-.:()()- 12 9 0 1 0 0 1
(anhydrous), azeotropically (anhydrous), ( (a (an (anh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 11 (),[],,.;();(),,; 17 10 0 1 0 0 1
(d) neutralization (d) ( (d (d) (d) BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 11 (),. 4 5 0 1 0 0 1
ARTICLE ARTICLE article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 3 11 no 0 10 0 1 0 0 0
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 3 11 :./ 3 10 0 1 0 0 0
6 6 6 6 6 6 6 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 11 no 0 10 0 0 0 0 0
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 3 11 ::./../ 7 10 0 0 1 0 0
fluorobenzoic acid fluorobenzoic f fl flu fluo BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 (), 3 10 0 1 0 0 1
preparative HPLC preparative p pr pre prep BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 -[()--(---[-()---- 18 9 0 1 0 0 1
methyl-1H-pyrazol-4-yl]pyridin-3-yl}oxy)ethyl]-4-fluorobenzoic acid methyl-1h-pyrazol-4-yl]pyridin-3-yl}oxy)ethyl]-4-fluorobenzoic m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 ----]--)]--()- 14 9 0 1 0 0 1
(70 mg, (70 ( (7 (70 (70 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 (,).()/.[]. 11 8 0 1 0 0 1
(10R)-7-amino-12-fluoro-2,10-dimethyl-15-oxo-10,15,16,17-tetrahydro-2H- (10R)-7-amino-12-fluoro-2,10-dimethyl-15-oxo-10,15,16,17-tetrahydro-2H- (10r)-7-amino-12-fluoro-2,10-dimethyl-15-oxo-10,15,16,17-tetrahydro-2h- ( (1 (10 (10R BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 ()-----,----,,,--- 18 7 0 1 0 0 1
8,4-(metheno) pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-car- 8,4-(metheno) 8 8, 8,4 8,4- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 ,-()[,-][,,]--- 15 7 0 1 0 0 1
bonitrile (R)-2. bonitrile b bo bon boni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 ()-.()-(,.),-- 14 8 0 1 0 0 1
pylethylamine (DIPEA) pylethylamine p py pyl pyle BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 ()(,.)() 8 7 0 1 0 0 1
À 35 à À À À À BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 0 -()(,.) 7 8 0 1 0 0 1
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI) 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 1 1- 1-E 1-Et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 ---(-)()(,.) 12 8 0 1 0 0 1
DMF (10 dmf D DM DMF DMF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 ()., 4 8 0 1 0 0 1
at 80 at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,. 2 8 0 1 0 0 1
mixture was mixture m mi mix mixt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ()(). 5 8 0 1 0 0 1
The combined the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 (), 3 7 0 1 0 0 1
Na 2 na N Na Na Na BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 3 0 , 1 9 0 1 0 0 1
preparative TLC, preparative p pr pre prep BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 ,()-- 5 8 0 1 0 0 1
amino-12-fluoro-2,10-dimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)- amino-12-fluoro-2,10-dimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)- amino-12-fluoro-2,10-dimethyl-15-oxo-10,15,16,17-tetrahydro-2h-8,4-(metheno)- a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 ---,----,,,---,-()- 19 8 0 1 0 0 1
pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile (R)-2 pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile p py pyr pyra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 [,-][,,]--()-(., 16 9 0 1 0 0 1
17%) as 17%) 1 17 17% 17%) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 ), 2 8 0 1 0 0 1
of cis of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (:).()/.[]; 11 8 0 1 0 0 1
Major (600 major M Ma Maj Majo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 3 0 (,).(,.,.,),.(,),.(, 20 9 0 1 0 0 1
J ¼ j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 0 .,.,.(,),.(,.,.,),.(,.,), 25 10 0 1 0 0 1
5.59 (d, 5.59 5 5. 5.5 5.59 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 .(,.,),.(,.,),.(,),.(,., 24 9 0 1 0 0 1
3 H); 3 3 3 3 3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 0 );(,).,.(,.),., 15 8 0 1 0 0 1
145.84, 143.83 145.84, 1 14 145 145. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 .,.(,.),.,.,.(,.),. 19 8 0 1 0 0 1
(d, J (d, ( (d (d, (d, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 (,.),.,.,.(,.),.(,.), 21 9 0 1 0 0 1
115.22, 114.83, 115.22, 1 11 115 115. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 .,.,.,.,.,.,.;(,) 17 8 0 1 0 0 1
d À d d d d d BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 3 0 .,.( 4 9 0 1 0 0 1
0 p.p.m. 0 0 0 0 0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 0 ...).(,).(,),.(,., 18 8 0 1 0 0 1
2.6 Hz, 2.6 2 2. 2.6 2.6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 .,),.(,.,.,),.(,.,.,),. 23 9 0 1 0 0 1
(q, J (q, ( (q (q, (q, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 (,.,),.(,.,),.(,),.(,., 23 9 0 1 0 0 1
1 H), 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 0 ),.(,);(,).,.(,. 16 8 0 1 0 0 1
Hz), 151.94, hz), H Hz Hz) Hz), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 ),.,.,.(,.),.,.,.(,.), 22 9 0 1 0 0 1
130.00 (d, 130.00 1 13 130 130. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 .(,.),.,.,.(,.),.(,. 20 9 0 1 0 0 1
Hz), 115.34, hz), H Hz Hz) Hz), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 ),.,.,.,.,.,.,.;(, 18 8 0 1 0 0 1
CD 3 cd C CD CD CD BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 ).,.( 5 8 0 1 0 0 1
CFCl 3 cfcl C CF CFC CFCl BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 ...). 5 3 0 1 0 0 1
Methyl 2-[(1R)-1-({2-[bis(tert-butoxycarbonyl)amino]-5-bromopyridin-3- methyl M Me Met Meth BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 3 -[()--(-[(-)]---- 17 8 0 0 0 0 1
yl}oxy)ethyl]-4-fluorobenzoate (R)-20. yl}oxy)ethyl]-4-fluorobenzoate y yl yl} yl}o BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 )]--()-.- 9 9 0 0 0 0 1
{(1R)-1-[(2-amino-5-bromopyridin-3-yl)oxy]ethyl}-4-fluorobenzoate (R)-15 {(1r)-1-[(2-amino-5-bromopyridin-3-yl)oxy]ethyl}-4-fluorobenzoate { {( {(1 {(1R BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 ()--[(-----)]--()-(., 21 9 0 0 0 0 1
8.126 mmol) 8.126 8 8. 8.1 8.12 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 .)()(.,.) 9 9 0 0 0 0 1
and DMAP and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 (,.). 5 8 0 0 0 0 1
manner, a manner, m ma man mann BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 ,(.,.)(). 9 10 0 0 0 0 1
reaction mixture reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 .(//, 5 9 0 0 0 0 1
ultraviolet, 254 ultraviolet, u ul ult ultr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 ,), 3 8 0 0 0 0 1
and a and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 . 1 9 0 0 0 0 1
CH 2 ch C CH CH CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 3 (),(),, 7 10 0 0 0 0 1
concentrated to concentrated c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 , 1 9 0 0 0 0 1
chromatography (petroleum chromatography c ch chr chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 (//)-[()--(-[ 13 9 0 0 0 0 1
(tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl}oxy)ethyl]-4-fluorobenzoate (tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl}oxy)ethyl]-4-fluorobenzoate (tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl}oxy)ethyl]-4-fluorobenzoate ( (t (te (ter BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 (-)]----)]-- 12 9 0 0 0 0 1
(R)-20 (3.5 (r)-20 ( (R (R) (R)- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 ()-(.,).(,).-. 14 9 0 0 0 0 1
(m, 2 (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 (,),.(,,),.(,),.-.(,),. 23 9 0 0 0 0 1
(q, J (q, ( (q (q, (q, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 (,.,),.(,),.(,.,),.(,). 23 9 0 0 0 0 1
2-[(1R)-1-({2-[bis(tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl}ox- 2-[(1R)-1-({2-[bis(tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl}ox- 2-[(1r)-1-({2-[bis(tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl}ox- 2 2- 2-[ 2-[( BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 -[()--(-[(-)]----- 18 7 0 0 0 0 1
y)ethyl]-4-fluorobenzoic acid y)ethyl]-4-fluorobenzoic y y) y)e y)et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 )]--()-.-[()--(- 16 8 0 0 0 0 1
[bis(tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl}oxy)ethyl]-4-fluor- [bis(tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl}oxy)ethyl]-4-fluor- [bis(tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl}oxy)ethyl]-4-fluor- [ [b [bi [bis BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 [(-)]----)]--- 14 8 0 0 0 0 1
obenzoate (R)-20 obenzoate o ob obe oben BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 4 ()-(.,.)(.) 11 9 0 0 0 0 1
(THF) (15.4 (thf) ( (T (TH (THF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 4 ()(.,)(., 9 8 0 0 0 0 1
9.22 mmol, 9.22 9 9. 9.2 9.22 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 .,)..( 6 9 0 0 0 0 1
ether/EtOAc 6/1) ether/etoac e et eth ethe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 4 //). 4 8 0 0 0 0 1
mixture was mixture m mi mix mixt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 , 1 9 0 0 0 0 1
was concentrated was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 . 1 8 0 0 0 0 1
(3 Â (3 ( (3 (3 (3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 (),(), 6 9 0 0 0 0 1
over Na over o ov ove over BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 ,. 2 9 0 0 0 0 1
ether/EtOAc (10: ether/etoac e et eth ethe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 4 /(:,),-[()- 11 9 0 0 0 0 1
1-({2-[bis(tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl}oxy)ethyl]-4-fluor- 1-({2-[bis(tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl}oxy)ethyl]-4-fluor- 1-({2-[bis(tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl}oxy)ethyl]-4-fluor- 1 1- 1-( 1-({ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 -(-[(-)]----)]--- 17 8 0 0 0 0 1
obenzoic acid obenzoic o ob obe oben BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 4 ()-(.,).(,) 11 9 0 0 0 0 1
8.24-8.20 (m, 8.24-8.20 8 8. 8.2 8.24 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 .-.(,),.(,),.(,.,),.(,),.-. 27 10 0 0 0 0 1
(m, 1 (m, ( (m (m, (m, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 4 (,),.-.(,),.(,.,),.(,). 23 8 0 0 0 0 1
3-(Aminomethyl)-1-methyl-1H-pyrazole-5-carbonitrile hydrochloride 3-(aminomethyl)-1-methyl-1h-pyrazole-5-carbonitrile 3 3- 3-( 3-(A BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 -()------. 10 9 0 0 0 0 1
stirred colourless stirred s st sti stir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 --[(------- 11 9 0 0 0 0 1
yl)methyl]imidodicarbonate 10 yl)methyl]imidodicarbonate y yl yl) yl)m BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 )](.,.)() 9 9 0 0 0 0 1
HCl(g) in hcl(g) H HC HCl HCl( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 ()(,)., 7 9 0 0 0 0 1
solution was solution s so sol solu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 , 1 10 0 0 0 0 1
2 h. 2 2 2 2 2 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 4 6 .,,(/ 5 10 0 1 0 0 1
EtOAc 10/1) etoac E Et EtO EtOA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 6 /)--[(------- 13 9 0 1 0 0 1
yl)methyl]imidodicarbonate had yl)methyl]imidodicarbonate y yl yl) yl)m BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 )]. 3 8 0 1 0 0 1
concentrated to concentrated c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 -()------ 9 9 0 1 0 0 1
hydrochloride 22 hydrochloride h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 (,), 4 9 0 1 0 0 1
purification. purification. purification. p pu pur puri BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 . 1 1 0 1 0 0 1
Tert-Butyl N-{5-bromo-3-[(1R)-1-(2-{[(5-cyano-1-methyl-1H-pyrazol-3-yl) tert-butyl T Te Ter Tert BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 6 -----[()--(-[(-------) 22 8 0 1 0 0 1
methyl]carbamoyl}-5-fluorophenyl)ethoxy]pyridin-2-yl}-N-(tert- methyl]carbamoyl}-5-fluorophenyl)ethoxy]pyridin-2-yl}-N-(tert- methyl]carbamoyl}-5-fluorophenyl)ethoxy]pyridin-2-yl}-n-(tert- m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 ]--)]----(- 11 7 0 1 0 0 1
butoxycarbonyl) glycinate butoxycarbonyl) b bu but buto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 )()-.-[()--(- 13 8 0 1 0 0 1
[bis(tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl}oxy)ethyl]-4-fluorobenzoic [bis(tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl}oxy)ethyl]-4-fluorobenzoic [bis(tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl}oxy)ethyl]-4-fluorobenzoic [ [b [bi [bis BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 [(-)]----)]-- 13 9 0 1 0 0 1
acid (R)-21 acid a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 ()-(.,.)-()------ 17 8 0 1 0 0 1
carbonitrile hydrochloride carbonitrile c ca car carb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 (.,.)-() 8 9 0 1 0 0 1
at o35 at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 (.,.). 6 8 0 1 0 0 1
addition was addition a ad add addi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 ,. 2 8 0 1 0 0 1
(7.79 g, (7.79 ( (7 (7. (7.7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 (.,.,)-, 8 9 0 1 0 0 1
and then and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 . 1 9 0 1 0 0 1
TLC (petroleum tlc T TL TLC TLC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 6 (//,.)()- 9 8 0 1 0 0 1
consumed. The consumed. c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 .- 2 9 0 1 0 0 1
(100 ml) (100 ( (1 (10 (100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 ()(),. 6 9 0 1 0 0 1
washed with washed w wa was wash BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 (),(),, 7 10 0 1 0 0 1
and concentrated and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 , 1 8 0 1 0 0 1
silica gel silica s si sil sili BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 /:- 3 8 0 1 0 0 1
N-{5-bromo-3-[(1R)-1-(2-{[(5-cyano-1-methyl-1H-pyrazol-3-yl)methyl] N-{5-bromo-3-[(1R)-1-(2-{[(5-cyano-1-methyl-1H-pyrazol-3-yl)methyl] n-{5-bromo-3-[(1r)-1-(2-{[(5-cyano-1-methyl-1h-pyrazol-3-yl)methyl] N N- N-{ N-{5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 ----[()--(-[(-------)] 22 7 0 1 0 0 1
carbamoyl}-5-fluorophenyl)ethoxy]pyridin-2-yl}-N-(tert-butoxycarbonyl)glycinate carbamoyl}-5-fluorophenyl)ethoxy]pyridin-2-yl}-N-(tert-butoxycarbonyl)glycinate carbamoyl}-5-fluorophenyl)ethoxy]pyridin-2-yl}-n-(tert-butoxycarbonyl)glycinate c ca car carb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 --)]----(-) 11 9 0 1 0 0 1
(R)-23 (3.4 (r)-23 ( (R (R) (R)- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 ()-(.,).()/.[]; 15 9 0 1 0 0 1
(400 MHz, (400 ( (4 (40 (400 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 (,).-.(,),.-.(,),.-.(,), 24 9 0 1 0 0 1
7.03-6.99 (m, 7.03-6.99 7 7. 7.0 7.03 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 .-.(,),.-.(,),.-.(,),.-.(,), 28 9 0 1 0 0 1
4.65 (t, 4.65 4 4. 4.6 4.65 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 .(,.,),.(,),.(,.,),.(,). 24 9 0 1 0 0 1
Di-tert-butyl [(10R)-3-cyano-12-fluoro-2,10-dimethyl-15-oxo-10,15,16,17- di-tert-butyl D Di Di- Di-t BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 8 --[()-----,----,,,- 19 8 0 0 0 0 1
tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclote- tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclote- tetrahydro-2h-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclote- t te tet tetr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 --,-()[,-][,,]- 15 7 0 0 0 0 1
tradecin-7-yl]imidodicarbonate (R)-3. tradecin-7-yl]imidodicarbonate t tr tra trad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 --]()-. 7 8 0 0 0 0 1
solution of solution s so sol solu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 -----[()--(-[(------ 20 8 0 0 0 0 1
3-yl)methyl]carbamoyl}-5-fluorophenyl)ethoxy]pyridin-2-yl}-N-(tert-butox- 3-yl)methyl]carbamoyl}-5-fluorophenyl)ethoxy]pyridin-2-yl}-N-(tert-butox- 3-yl)methyl]carbamoyl}-5-fluorophenyl)ethoxy]pyridin-2-yl}-n-(tert-butox- 3 3- 3-y 3-yl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 -)]--)]----(-- 14 8 0 0 0 0 1
ycarbonyl)glycinate (R)-23 ycarbonyl)glycinate y yc yca ycar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 8 )()-(,.),(,.), 14 8 0 0 0 0 1
Pd(OAc) 2 pd(oac) P Pd Pd( Pd(O BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 8 ()(.,.)(.,.)--- 15 8 0 0 0 0 1
butanol (10 butanol b bu but buta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 8 ().(.,.), 9 8 0 0 0 0 1
mixture was mixture m mi mix mixt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 . 1 9 0 0 0 0 1
stirred at stirred s st sti stir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 .(/ 3 8 0 0 0 0 1
1:1) showed 1:1) 1 1: 1:1 1:1) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 :)-----[()--(-[(----- 21 8 0 0 0 0 1
pyrazol-3-yl)methyl]carbamoyl}-5-fluorophenyl)ethoxy]pyridin-2-yl}-N- pyrazol-3-yl)methyl]carbamoyl}-5-fluorophenyl)ethoxy]pyridin-2-yl}-N- pyrazol-3-yl)methyl]carbamoyl}-5-fluorophenyl)ethoxy]pyridin-2-yl}-n- p py pyr pyra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 --)]--)]---- 12 7 0 0 0 0 1
(tert-butoxycarbonyl)glycinate had (tert-butoxycarbonyl)glycinate ( (t (te (ter BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 8 (-), 4 8 0 0 0 0 1
detected. The detected. d de det dete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 .-(), 5 9 0 0 0 0 1
EtOAc (3 etoac E Et EtO EtOA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 8 ().(), 6 8 0 0 0 0 1
dried over dried d dr dri drie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 , 1 9 0 0 0 0 1
solid. Initial solid. s so sol soli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 .(/ 3 9 0 0 0 0 1
1/3, R 1/3, 1 1/ 1/3 1/3, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 /,.), 5 9 0 0 0 0 1
purified by purified p pu pur puri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 --[()----- 10 8 0 0 0 0 1
2,10-dimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h] 2,10-dimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h] 2,10-dimethyl-15-oxo-10,15,16,17-tetrahydro-2h-8,4-(metheno)pyrazolo[4,3-h] 2 2, 2,1 2,10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 ,----,,,---,-()[,-] 19 8 0 0 0 0 1
[2,5,11]benzoxadiazacyclotetradecin-7-yl]imidodicarbonate (R)-3 [2,5,11]benzoxadiazacyclotetradecin-7-yl]imidodicarbonate [ [2 [2, [2,5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 [,,]--]()-(,) 13 9 0 0 0 0 1
an off-white an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 8 -.()/ 5 9 0 0 0 0 1
593.1 [M 593.1 5 59 593 593. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 .[];(, 6 8 0 0 0 0 1
CD 3 cd C CD CD CD BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 8 ).(,),.(,.),.-.(,),.-.(,), 26 9 0 0 0 0 1
6.51-6.49 (m, 6.51-6.49 6 6. 6.5 6.51 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 .-.(,.),.-.(,.),.-.(,.),.-. 27 8 0 0 0 0 1
(m, 1 (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 8 (,),.-.(,),.-.(,),.-.(,); 25 9 0 0 0 0 1
(101 MHz, (101 ( (1 (10 (101 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 (,).,.,.,.,.,.,., 17 8 0 0 0 0 1
142.58, 138.93. 142.58, 1 14 142 142. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 .,...,.,.,.,.,.,.,., 20 9 0 0 0 0 1
114.74, 114.61, 114.74, 1 11 114 114. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 .,.,.,.,.,.,.,.,.,.,.,., 24 10 0 0 0 0 1
19.58; 19 19.58; 1 19 19. 19.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 .;(,).,.( 9 9 0 0 0 0 1
relative to relative r re rel rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 ...). 5 6 0 0 0 0 1
The synthesis the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 8 --[(-----)]-- 13 8 0 0 0 0 1
nitrobenzoate 31 nitrobenzoate n ni nit nitr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 8 (.). 4 6 0 0 0 0 1
1-(2-Amino-5-nitrophenyl)ethanone 25. 1-(2-amino-5-nitrophenyl)ethanone 1 1- 1-( 1-(2 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 10 -(---).-(---) 13 9 0 0 0 0 1
ethanone 24 ethanone e et eth etha BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 10 (,)()() 7 8 0 0 0 0 1
stirred at stirred s st sti stir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 .(/:) 5 9 0 0 0 0 1
of 1-(2-fluoro-5-nitrophenyl)ethanone of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 -(---) 6 8 0 0 0 0 1
detected. The detected. d de det dete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 ., 2 9 0 0 0 0 1
was extracted was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 (). 3 9 0 0 0 0 1
(400 ml), (400 ( (4 (40 (400 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 10 (),, 4 10 0 0 0 0 1
was purified was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 (/: 3 9 0 0 0 0 1
3:1) to 3:1) 3 3: 3:1 3:1) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 10 :)-(---)(,). 12 9 0 0 0 0 1
1 H 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 10 (,).(,,),.-.(,),. 17 9 0 0 0 0 1
(d, J (d, ( (d (d, (d, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 10 (,.,),.(,). 11 4 0 0 0 0 1
1-(2-Iodo-5-nitrophenyl)ethanone 26. 1-(2-iodo-5-nitrophenyl)ethanone 1 1- 1-( 1-(2 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 11 -(---).-(--- 12 9 0 0 0 0 1
nitrophenyl)ethanone 25 nitrophenyl)ethanone n ni nit nitr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 11 )(,)(.,) 8 10 0 0 0 0 1
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 :./ 3 10 0 1 0 0 0
ARTICLE ARTICLE article A AR ART ARTI BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 10 0 1 0 0 0
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 ::./../ 7 10 0 0 0 0 0
7 7 7 7 7 7 7 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 11 no 0 10 0 0 0 0 0
in CH in i in in in BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 0 ()(,) 5 9 0 1 0 0 1
portion. The portion. p po por port BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ..(/ 4 9 0 1 0 0 1
EtOAc ¼ etoac E Et EtO EtOA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 /)-(---) 8 8 0 1 0 0 1
consumed with consumed c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 9 0 1 0 0 1
under vacuum, under u un und unde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ,( 2 9 0 1 0 0 1
ether/EtOAc ¼ ether/etoac e et eth ethe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 /:)-(---)(,) 12 10 0 1 0 0 1
yellow solid. yellow y ye yel yell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .(,).(,.,),. 12 9 0 1 0 0 1
(d, J (d, ( (d (d, (d, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 (,.,.-.(,),.(,). 16 6 0 1 0 0 1
1-(2-Iodo-5-nitrophenyl)ethanol 27. 1-(2-iodo-5-nitrophenyl)ethanol 1 1- 1-( 1-(2 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 -(---).-(---- 13 9 0 0 0 0 1
phenyl)ethanone 26 phenyl)ethanone p ph phe phen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 )(,.)() 7 8 0 0 0 0 1
(5.62 g, (5.62 ( (5 (5. (5.6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 (.,)., 6 10 0 0 0 0 1
stirred at stirred s st sti stir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .(/:) 5 9 0 0 0 0 1
that the that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -(---) 6 9 0 0 0 0 1
being detected. being b be bei bein BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .(), 4 9 0 0 0 0 1
concentrated. The concentrated. c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .()(). 6 9 0 0 0 0 1
The organic the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 (), 3 8 0 0 0 0 1
concentrated in concentrated c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 , 1 8 0 0 0 0 1
chromatography (petroleum chromatography c ch chr chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 (/::)-(--- 10 8 0 0 0 0 1
nitrophenyl)ethanol 27 nitrophenyl)ethanol n ni nit nitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 )(,).(,) 8 9 0 0 0 0 1
d 8.43-8.42 d d d d d BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 5 0 .-.(,),.-.(,),.(,.,),.-. 24 9 0 0 0 0 1
(m, 1 (m, ( (m (m, (m, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 (,),.-.(,),.-.(,). 18 5 0 0 0 0 1
1-(2-Iodo-5-nitrophenyl)ethyl methanesulfonate 1-(2-iodo-5-nitrophenyl)ethyl 1 1- 1-( 1-(2 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 -(---). 7 9 0 0 0 0 1
1-(2-iodo-5-nitrophenyl)ethanol 27 1-(2-iodo-5-nitrophenyl)ethanol 1 1- 1-( 1-(2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 -(---)(,.),(.,.) 16 9 0 0 0 0 1
and TEA and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 (.,)() 6 9 0 0 0 0 1
MsCl (23.5 mscl M Ms MsC MsCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 1 (.,)., 6 9 0 0 0 0 1
allowed to allowed a al all allo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 .(/ 3 9 0 0 0 0 1
EtOAc ¼ etoac E Et EtO EtOA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 1 :)-(---), 9 9 0 0 0 0 1
one new one o on one one BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 .(), 4 9 0 0 0 0 1
washed with washed w wa was wash BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 ()(),- 6 9 0 0 0 0 1
centrated to centrated c ce cen cent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 1 -(---) 6 9 0 0 0 0 1
(37.99 g), (37.99 ( (3 (37 (37. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 (.),. 5 10 0 0 0 0 1
3-[1-(2-Iodo-5-nitrophenyl)ethoxy]pyridin-2-amine 29. 3-[1-(2-iodo-5-nitrophenyl)ethoxy]pyridin-2-amine 3 3- 3-[ 3-[1 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 2 -[-(---)]--.-(- 15 8 0 0 0 0 1
iodo-5-nitrophenyl)ethyl methanesulfonate iodo-5-nitrophenyl)ethyl i io iod iodo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 2 --)(.,.),-- 11 9 0 0 0 0 1
2-aminopyridine (12.4 2-aminopyridine 2 2- 2-a 2-am BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 2 -(.,)(,) 8 9 0 0 0 0 1
(400 ml) (400 ( (4 (40 (400 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 2 ().(/) 6 9 0 0 0 0 1
1-(2-iodo-5-nitrophenyl)ethyl methanesulfonate 1-(2-iodo-5-nitrophenyl)ethyl 1 1- 1-( 1-(2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 2 -(---) 6 9 0 0 0 0 1
new spots new n ne new new BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 ., 2 9 0 0 0 0 1
under vacuum. under u un und unde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 .(), 4 9 0 0 0 0 1
(200 ml) (200 ( (2 (20 (200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 2 ()(),. 6 9 0 0 0 0 1
residue was residue r re res resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 (/ 2 9 0 0 0 0 1
5:1 to 5:1 5 5: 5:1 5:1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 2 ::)-[-(---)]--(., 17 9 0 0 0 0 1
38%) as 38%) 3 38 38% 38%) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 2 ).(,).(,.,), 12 9 0 0 0 0 1
8.05 (d, 8.05 8 8. 8.0 8.05 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 2 .(,.,),.-.(,),.(,.,),.-. 24 10 0 0 0 0 1
(m, 2 (m, ( (m (m, (m, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 2 (,),.(,.,),.(,),.(,.,). 23 9 0 0 0 0 1
Methyl 2-{1-[(2-aminopyridin-3-yl)oxy]ethyl}-4-nitrobenzoate methyl M Me Met Meth BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 3 --[(---)]--. 12 7 0 0 0 0 1
A mixture a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 5 3 -[-(---)]--(., 14 9 0 0 0 0 1
39.21 mmol), 39.21 3 39 39. 39.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 .),(.,.)()(.,.) 15 9 0 0 0 0 1
MeOH (180 meoh M Me MeO MeOH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 3 ()() 4 8 0 0 0 0 1
pressure for pressure p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 .(/:)-[-(--- 12 9 0 0 0 0 1
nitrophenyl)ethoxy]pyridin-2-amine had nitrophenyl)ethoxy]pyridin-2-amine n ni nit nitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 )]--, 5 9 0 0 0 0 1
being detected. being b be bei bein BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 ., 2 9 0 0 0 0 1
in EtOAc in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 3 ()()(). 7 9 0 0 0 0 1
phase was phase p ph pha phas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 ,, 2 9 0 0 0 0 1
residue purified residue r re res resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 (/: 3 9 0 0 0 0 1
1:1) to 1:1) 1 1: 1:1 1:1) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 :)--[(---)]-- 13 9 0 0 0 0 1
(7.51 g, (7.51 ( (7 (7. (7.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 (.,).(,).(,., 13 10 0 0 0 0 1
1 H), 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 3 ),.-.(,),.(,.,),.(,.,), 23 9 0 0 0 0 1
6.47-6.45 (m, 6.47-6.45 6 6. 6.4 6.47 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 .-.(,),.-.(,),.(,),.(,),. 25 9 0 0 0 0 1
(d, J (d, ( (d (d, (d, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 3 (,.,). 6 2 0 0 0 0 1
Ethyl 2-{1-[(2-amino-5-bromopyridin-3-yl)oxy]ethyl}-4-nitrobenzoate ethyl E Et Eth Ethy BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 5 5 --[(-----)]--. 14 8 0 0 0 0 1
To a to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 5 --[(---)]-- 11 8 0 0 0 0 1
nitrobenzoate 30 nitrobenzoate n ni nit nitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 (.,.)()-- 9 9 0 0 0 0 1
succinimide (NBS) succinimide s su suc succ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 ()(.,.). 8 9 0 0 0 0 1
complete, the complete, c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ,.(/ 4 10 0 0 0 0 1
EtOAc ¼ etoac E Et EtO EtOA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 :)--[(---)]--- 14 9 0 0 0 0 1
benzoate had benzoate b be ben benz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 ,. 2 9 0 0 0 0 1
mixture was mixture m mi mix mixt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 () 2 9 0 0 0 0 1
(2 Â (2 ( (2 (2 (2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 ().(), 6 9 0 0 0 0 1
Na 2 na N Na Na Na BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 5 5 .- 2 9 0 0 0 0 1
matography (petroleum matography m ma mat mato BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 (/::)--[(- 10 9 0 0 0 0 1
amino-5- amino-5- amino-5- a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 -- 2 0 0 0 0 0 1
bromopyridin-3-yl)oxy]ethyl}-4-nitrobenzoate 31 bromopyridin-3-yl)oxy]ethyl}-4-nitrobenzoate b br bro brom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 --)]--(.,). 11 9 0 0 0 0 1
LCMS (APCI) lcms L LC LCM LCMS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 ()/.[];(,). 11 8 0 0 0 0 1
(d, J (d, ( (d (d, (d, BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 (,.,),.-.(,),.(,),.(,.,), 25 10 0 1 0 0 1
6.30-6.28 (m, 6.30-6.28 6 6. 6.3 6.30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 .-.(,),.(,),.(,),.(,.,). 24 9 0 1 0 0 1
The synthesis the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 6 -., 3 9 0 1 0 0 1
and for and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 no 0 9 0 1 0 0 1
group of group g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 .(.), 5 8 0 1 0 0 1
macrocycle 4 macrocycle m ma mac macr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 -, 2 9 0 1 0 0 1
as shown as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 .., 3 9 0 1 0 0 1
which undergoes which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 , 1 10 0 1 0 0 1
reactions such reactions r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 , 1 9 0 1 0 0 1
macrolactamization precursor. macrolactamization m ma mac macr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 . 1 9 0 1 0 0 1
DMF leads dmf D DM DMF DMF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 6 ,. 2 7 0 1 0 0 1
The synthesis the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 6 --,,------,,,- 14 8 0 1 0 0 1
tetrahydro-2H-8,4-(metheno)pyrazolo [4,3-h][2,5,11]benzoxadiazacyclotetradecine- tetrahydro-2h-8,4-(metheno)pyrazolo t te tet tetr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 --,-()[,-][,,]- 15 9 0 1 0 0 1
3-carbonitrile 5 3-carbonitrile 3 3- 3-c 3-ca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 ---[--,,----- 13 8 0 1 0 0 1
oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno) pyrazolo[4,3-h][2,5,11] oxo-10,15,16,17-tetrahydro-2h-8,4-(metheno) o ox oxo oxo- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 -,,,---,-()[,-][,,] 19 8 0 1 0 0 1
benzoxadiazacyclotetradecin-7-yl]imidodicarbonate 4 benzoxadiazacyclotetradecin-7-yl]imidodicarbonate b be ben benz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 --](.) 6 9 0 1 0 0 1
described below. described d de des desc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 . 1 2 0 1 0 0 1
Methyl 2-(1-{[2-amino-5-(3-{[(tert-butoxycarbonyl)(methyl)amino]methyl}- methyl M Me Met Meth BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 7 -(-[---(-[(-)()]- 17 8 0 0 0 0 1
5-cyano-1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]oxy}ethyl)-4-nitrobenzoate 33. 5-cyano-1-methyl-1h-pyrazol-4-yl)pyridin-3-yl]oxy}ethyl)-4-nitrobenzoate 5 5- 5-c 5-cy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 7 -------)--])--. 15 9 0 0 0 0 1
A mixture a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 6 7 --[(-----)]-- 13 8 0 0 0 0 1
nitrobenzoate 31 nitrobenzoate n ni nit nitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 7 (.,.),-[(------- 16 9 0 0 0 0 1
pyrazol-3-yl)methyl]methylcarbamate 32 pyrazol-3-yl)methyl]methylcarbamate p py pyr pyra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 7 --)](.,.),(., 13 9 0 0 0 0 1
8.20 mmol) 8.20 8 8. 8.2 8.20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 7 .)(.,.)() 9 8 0 0 0 0 1
°C °C °c ° °C °C °C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 7 no 0 0 0 0 0 0 1
under a under u un und unde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 .()(.,.) 8 8 0 0 0 0 1
(0.452 g, (0.452 ( (0 (0. (0.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 7 (.,.)(), 8 9 0 0 0 0 1
stirred at stirred s st sti stir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 .(/:) 5 10 0 0 0 0 1
methyl 2-{1-[(2-amino-5-bromopyridin-3-yl)oxy]ethyl}-4-nitrobenzoate methyl m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 --[(-----)]-- 13 9 0 0 0 0 1
consumed with consumed c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 ., 2 9 0 0 0 0 1
diluted with diluted d di dil dilu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 (). 3 9 0 0 0 0 1
vacuo to vacuo v va vac vacu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 7 , 1 9 0 0 0 0 1
(petroleum ether/EtOAc (petroleum ( (p (pe (pet BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 7 (/::)-(-[---(- 14 9 0 0 0 0 1
{[(tert-butoxycarbonyl)(methyl)amino]methyl}-5-cyano-1-methyl-1H-pyrazol-4- {[(tert-butoxycarbonyl)(methyl)amino]methyl}-5-cyano-1-methyl-1H-pyrazol-4- {[(tert-butoxycarbonyl)(methyl)amino]methyl}-5-cyano-1-methyl-1h-pyrazol-4- { {[ {[( {[(t BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 7 [(-)()]-------- 15 9 0 0 0 0 1
yl)pyridin-3-yl]oxy}ethyl)-4-nitrobenzoate 33 yl)pyridin-3-yl]oxy}ethyl)-4-nitrobenzoate y yl yl) yl)p BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 7 )--])--(.,). 12 9 0 0 0 0 1
LCMS (APCI) lcms L LC LCM LCMS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 7 ()/.[]. 7 4 0 0 0 0 1
2-(1-{[2-Amino-5-(3-{[(tert-butoxycarbonyl)(methyl)amino]methyl}-5-cyano- 2-(1-{[2-Amino-5-(3-{[(tert-butoxycarbonyl)(methyl)amino]methyl}-5-cyano- 2-(1-{[2-amino-5-(3-{[(tert-butoxycarbonyl)(methyl)amino]methyl}-5-cyano- 2 2- 2-( 2-(1 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 -(-[---(-[(-)()]--- 19 9 0 0 0 0 1
1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]oxy}ethyl)-4-nitrobenzoic acid 1-methyl-1h-pyrazol-4-yl)pyridin-3-yl]oxy}ethyl)-4-nitrobenzoic 1 1- 1-m 1-me BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 -----)--])--. 13 9 0 0 0 0 1
A mixture a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 6 8 -(-[---(-[(-)()] 16 9 0 0 0 0 1
methyl}-5-cyano-1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]oxy}ethyl)-4- methyl}-5-cyano-1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]oxy}ethyl)-4- methyl}-5-cyano-1-methyl-1h-pyrazol-4-yl)pyridin-3-yl]oxy}ethyl)-4- m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 --------)--])-- 15 8 0 0 0 0 1
nitrobenzoate 33 nitrobenzoate n ni nit nitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 8 (.,.)(,.) 9 8 0 0 0 0 1
(50 ml) (50 ( (5 (50 (50 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 ()().(/ 7 9 0 0 0 0 1
EtOAc ¼ etoac E Et EtO EtOA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 8 :) 2 8 0 0 0 0 1
detected. The detected. d de det dete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 . 1 9 0 0 0 0 1
solution. The solution. s so sol solu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 ., 2 9 0 0 0 0 1
with 5% with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 . 1 9 0 0 0 0 1
(3 Â (3 ( (3 (3 (3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 (,(), 5 9 0 0 0 0 1
over Na over o ov ove over BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 -(-[---(-[(- 12 9 0 0 0 0 1
butoxycarbonyl)(methyl)amino]methyl}-5-cyano-1-methyl-1H-pyrazol-4-yl) butoxycarbonyl)(methyl)amino]methyl}-5-cyano-1-methyl-1H-pyrazol-4-yl) butoxycarbonyl)(methyl)amino]methyl}-5-cyano-1-methyl-1h-pyrazol-4-yl) b bu but buto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 )()]--------) 13 8 0 0 0 0 1
pyridin-3-yl]oxy}ethyl)-4-nitrobenzoic acid pyridin-3-yl]oxy}ethyl)-4-nitrobenzoic p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 --])--(), 9 10 0 0 0 0 1
was used was w wa was was BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 .()/.[]. 8 8 0 0 0 0 1
2-{1-[(2-Amino-5-{5-cyano-1-methyl-3-[(methylamino)methyl]-1H-pyrazol- 2-{1-[(2-Amino-5-{5-cyano-1-methyl-3-[(methylamino)methyl]-1H-pyrazol- 2-{1-[(2-amino-5-{5-cyano-1-methyl-3-[(methylamino)methyl]-1h-pyrazol- 2 2- 2-{ 2-{1 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 9 --[(--------[()]--- 19 8 0 0 0 0 1
4-yl}pyridin-3-yl)oxy]ethyl}-4-nitrobenzoic acid 4-yl}pyridin-3-yl)oxy]ethyl}-4-nitrobenzoic 4 4- 4-y 4-yl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 9 ---)]--. 8 9 0 0 0 0 1
2-(1-{[2-amino-5-(3-{[(tert-butoxycarbonyl)(methyl)amino]methyl}-5-cyano-1- 2-(1-{[2-amino-5-(3-{[(tert-butoxycarbonyl)(methyl)amino]methyl}-5-cyano-1- 2-(1-{[2-amino-5-(3-{[(tert-butoxycarbonyl)(methyl)amino]methyl}-5-cyano-1- 2 2- 2-( 2-(1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 9 -(-[---(-[(-)()]---- 20 9 0 0 0 0 1
methyl-1H-pyrazol-4-yl)pyridin-3-yl]oxy} ethyl)-4-nitrobenzoic methyl-1h-pyrazol-4-yl)pyridin-3-yl]oxy} m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 9 ----)--])--(., 14 9 0 0 0 0 1
3.54 mmol) 3.54 3 3. 3.5 3.54 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 9 .)() 4 8 0 0 0 0 1
(g)/EtOAc (20 (g)/etoac ( (g (g) (g)/ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 9 ()/()., 7 10 0 0 0 0 1
stirred at stirred s st sti stir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 . 1 9 0 0 0 0 1
main peak main m ma mai main BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 9 . 1 9 0 0 0 0 1
vacuo to vacuo v va vac vacu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 9 --[(-------- 12 9 0 0 0 0 1
[(methylamino)methyl]-1H-pyrazol-4-yl}pyridin-3-yl)oxy]ethyl}-4-nitrobenzoic [(methylamino)methyl]-1H-pyrazol-4-yl}pyridin-3-yl)oxy]ethyl}-4-nitrobenzoic [(methylamino)methyl]-1h-pyrazol-4-yl}pyridin-3-yl)oxy]ethyl}-4-nitrobenzoic [ [( [(m [(me BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 9 [()]------)]-- 14 9 0 0 0 0 1
acid 35 acid a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 (.), 4 9 0 0 0 0 1
without further without w wi wit with BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 .()/.[]. 8 7 0 0 0 0 1
7-Amino-2,10,16-trimethyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2H-8,4- 7-Amino-2,10,16-trimethyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2H-8,4- 7-amino-2,10,16-trimethyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2h-8,4- 7 7- 7-A 7-Am BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 10 --,,------,,,---,- 18 8 0 0 0 0 1
(metheno)pyrazolo [4,3-h][2,5,11]benzoxadiazacyclotetradecine-3- (metheno)pyrazolo ( (m (me (met BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 10 ()[,-][,,]-- 12 7 0 0 0 0 1
carbonitrile 5. carbonitrile c ca car carb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 10 .--[(----- 10 9 0 0 0 0 1
1-methyl-3-[(methylamino)methyl]-1H-pyrazol-4-yl}pyridin-3-yl)oxy]ethyl}-4- 1-methyl-3-[(methylamino)methyl]-1H-pyrazol-4-yl}pyridin-3-yl)oxy]ethyl}-4- 1-methyl-3-[(methylamino)methyl]-1h-pyrazol-4-yl}pyridin-3-yl)oxy]ethyl}-4- 1 1- 1-m 1-me BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 10 ---[()]------)]-- 17 8 0 0 0 0 1
nitrobenzoic acid nitrobenzoic n ni nit nitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 10 (,.)(,.) 8 9 0 0 0 0 1
(20 ml) (20 ( (2 (20 (20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 10 ()(,.) 6 9 0 0 0 0 1
(20 ml) (20 ( (2 (20 (20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 10 ().,. 5 9 0 0 0 0 1
indicated that indicated i in ind indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 . 1 8 0 0 0 0 1
evaporated under evaporated e ev eva evap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 ,(), 4 9 0 0 0 0 1
extracted with extracted e ex ext extr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 (). 3 9 0 0 0 0 1
Na 2 na N Na Na Na BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 6 10 (),(), 6 10 0 0 0 0 1
concentrated in concentrated c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 , 1 9 0 0 0 0 1
gel chromatography gel g ge gel gel BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 (,:/:,.) 8 9 0 0 0 0 1
ARTICLE ARTICLE article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 6 11 no 0 10 0 1 0 0 0
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 6 11 :./ 3 10 0 1 0 0 0
8 8 8 8 8 8 8 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 0
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 6 11 ::./../ 7 10 0 0 1 0 0
give the give g gi giv give BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 (), 3 8 0 1 0 0 1
TLC (silica tlc T TL TLC TLC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 (,/:,.)--,,-- 13 8 0 1 0 0 1
methyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo methyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo methyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2h-8,4-(metheno)pyrazolo m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 -----,,,---,-() 15 7 0 1 0 0 1
[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile 5 [4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile [ [4 [4, [4,3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 [,-][,,]--(,) 13 8 0 1 0 0 1
yellow solid. yellow y ye yel yell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 .()/.[];(,) 11 8 0 1 0 0 1
8.48 (d, 8.48 8 8. 8.4 8.48 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .(,.,),.(,.,),.(,),.(,., 24 10 0 1 0 0 1
H), 6.86 h), H H) H), H), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ),.(,),.(,.,),.(,),.(,., 24 9 0 1 0 0 1
H), 4.08 h), H H) H), H), BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ),.(,),.(,),.(,.,). 19 6 0 1 0 0 1
Di-tert-butyl [3-cyano-2,10,16-trimethyl-12-nitro-15-oxo-10,15,16,17- di-tert-butyl D Di Di- Di-t BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 --[--,,------,,,- 17 8 0 0 0 0 1
tetrahydro-2H-8,4-(metheno) pyrazolo[4,3-h][2,5,11]benzoxadiazacyclote- tetrahydro-2h-8,4-(metheno) t te tet tetr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 --,-()[,-][,,]- 15 8 0 0 0 0 1
tradecin-7-yl]imidodicarbonate 4. tradecin-7-yl]imidodicarbonate t tr tra trad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 --].--,,--- 11 9 0 0 0 0 1
nitro-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11] nitro-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11] nitro-15-oxo-10,15,16,17-tetrahydro-2h-8,4-(metheno)pyrazolo[4,3-h][2,5,11] n ni nit nitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 ---,,,---,-()[,-][,,] 21 9 0 0 0 0 1
benzoxadiazacyclotetradecine-3-carbonitrile 5 benzoxadiazacyclotetradecine-3-carbonitrile b be ben benz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 --(,.),() 9 9 0 0 0 0 1
(1,510 mg, (1,510 ( (1 (1, (1,5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 0 (,,.)(.,.)() 12 9 0 0 0 0 1
stirred at stirred s st sti stir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 .(/:)-- 7 9 0 0 0 0 1
2,10,16-trimethyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno) 2,10,16-trimethyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno) 2,10,16-trimethyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2h-8,4-(metheno) 2 2, 2,1 2,10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 ,,------,,,---,-() 18 8 0 0 0 0 1
pyrazolo[4,3-h][2,5,11]benzoxadiaza cyclotetradecine-3-carbonitrile pyrazolo[4,3-h][2,5,11]benzoxadiaza p py pyr pyra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 [,-][,,]-- 10 9 0 0 0 0 1
consumed with consumed c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 . 1 9 0 0 0 0 1
vacuo to vacuo v va vac vacu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 , 1 9 0 0 0 0 1
(CH 2 (ch ( (C (CH (CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 (/:). 5 9 0 0 0 0 1
preparative TLC preparative p pr pre prep BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 (/:,.,) 7 10 0 0 0 0 1
di-tert-butyl [3-cyano-2,10,16-trimethyl-12-nitro-15-oxo-10,15,16,17-tetrahydro- di-tert-butyl d di di- di-t BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 --[--,,------,,,-- 18 9 0 0 0 0 1
2H-8,4-(metheno) pyrazolo 2h-8,4-(metheno) 2 2H 2H- 2H-8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 -,-()[,-][,,]--] 16 9 0 0 0 0 1
imidodicarbonate 4 imidodicarbonate i im imi imid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 (,).()/. 8 8 0 0 0 0 1
[M þ [m [ [M [M [M BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 [];(,).(,.,),.(,), 18 10 0 0 0 0 1
8.18-8.16 (m, 8.18-8.16 8 8. 8.1 8.18 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .-.(,),.(,.,),.(,),.-.(,), 26 9 0 0 0 0 1
4.48-4.38 (m, 4.48-4.38 4 4. 4.4 4.48 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .-.(,),.(,),.(,),.(,.,),. 25 9 0 0 0 0 1
(s, 18 (s, ( (s (s, (s, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 (,). 4 1 0 0 0 0 1
Separation of separation S Se Sep Sepa BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 2 ()--(---)()--(--- 17 8 0 0 0 0 1
nitrophenyl)ethanol. The nitrophenyl)ethanol. n ni nit nitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 2 ). 2 9 0 0 0 0 1
Chiralpak AD-3 chiralpak C Ch Chi Chir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 2 -(...,), 8 8 0 0 0 0 1
5-40% isopropanol 5-40% 5 5- 5-4 5-40 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 -()(.())( 9 8 0 0 0 0 1
Fig. 6). fig. F Fi Fig Fig. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 2 .)..().() 9 10 0 0 0 0 1
5.65 min. 5.65 5 5. 5.6 5.65 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 ..() 4 8 0 0 0 0 1
(Chiralpak AD (chiralpak ( (C (Ch (Chi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 2 (..,, 5 8 0 0 0 0 1
IPA with ipa I IP IPA IPA BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 2 . 1 2 0 0 0 0 1
4 4 4 4 4 4 4 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 3 no 0 10 0 0 0 0 1
OH at oh O OH OH OH BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 3 )(()-) 6 7 0 0 0 0 1
as a as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 (.,)(()-)(.,). 14 9 0 0 0 0 1
(1R)-1-(2-iodo-5-nitrophenyl)ethanol (Peak (1r)-1-(2-iodo-5-nitrophenyl)ethanol ( (1 (1R (1R) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 3 ()--(---)().. 13 7 0 0 0 0 1
(R)-enantiomer by (r)-enantiomer ( (R (R) (R)- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 3 ()-. 4 4 0 0 0 0 1
(1S)-1-(2-iodo-5-nitrophenyl)ethanol (Peak (1s)-1-(2-iodo-5-nitrophenyl)ethanol ( (1 (1S (1S) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 3 ()--(---)()..(, 15 8 0 0 0 0 1
CDCl 3 cdcl C CD CDC CDCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 3 ).(,.,),.(,.,),.-.(,), 22 10 0 0 0 0 1
5.12 (q, 5.12 5 5. 5.1 5.12 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 3 .(,.,),.(,),.(,.,). 19 8 0 0 0 0 1
The synthesis the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 3 --,,------,,,- 14 8 0 0 0 0 1
tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine- tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine- tetrahydro-2h-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine- t te tet tetr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 3 --,-()[,-][,,]- 15 9 0 0 0 0 1
3-carbonitrile, 4 3-carbonitrile, 3 3- 3-c 3-ca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 3 -,(.) 5 9 0 0 0 0 1
below. below. below. b be bel belo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 . 1 0 0 0 0 0 1
Methyl 2-[1-({2-[bis(tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl}oxy) methyl M Me Met Meth BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 4 -[-(-[(-)]----) 15 8 0 0 0 0 1
ethyl]-4-nitrobenzoate 36. ethyl]-4-nitrobenzoate e et eth ethy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 ]--.--[(- 9 8 0 0 0 0 1
amino-5-bromopyridin-3-yl)oxy]ethyl}-4-nitrobenzoate 31 amino-5-bromopyridin-3-yl)oxy]ethyl}-4-nitrobenzoate a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 ----)]--(.,.) 13 9 0 0 0 0 1
dry CH dry d dr dry dry BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 ()(.,)(., 9 8 0 0 0 0 1
23.9 mmol). 23.9 2 23 23. 23.9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 .).(.,) 7 9 0 0 0 0 1
manner, and manner, m ma man mann BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 ,. 2 9 0 0 0 0 1
TLC (petroleum tlc T TL TLC TLC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 4 (/:)--[(- 9 8 0 0 0 0 1
amino-5-bromopyridin-3-yl)oxy]ethyl}-4-nitrobenzoate had amino-5-bromopyridin-3-yl)oxy]ethyl}-4-nitrobenzoate a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 ----)]--, 9 8 0 0 0 0 1
major new major m ma maj majo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 4 .(), 4 9 0 0 0 0 1
washed with washed w wa was wash BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 (),, 4 10 0 0 0 0 1
residue as residue r re res resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 ,( 2 9 0 0 0 0 1
ether/EtOAc 3:1) ether/etoac e et eth ethe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 /:)-[-(-[(-)]-- 15 8 0 0 0 0 1
bromopyridin-3-yl}oxy)ethyl]-4-nitrobenzoate 36 bromopyridin-3-yl}oxy)ethyl]-4-nitrobenzoate b br bro brom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 --)]--(,)- 10 8 0 0 0 0 1
viscous oil. viscous v vi vis visc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 . 1 1 0 0 0 0 1
2-[1-({2-[Bis(tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl}oxy)ethyl]-4- 2-[1-({2-[Bis(tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl}oxy)ethyl]-4- 2-[1-({2-[bis(tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl}oxy)ethyl]-4- 2 2- 2-[ 2-[1 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 -[-(-[(-)]----)]-- 18 8 0 0 0 0 1
nitrobenzoic acid nitrobenzoic n ni nit nitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 .-[-(-[(- 9 8 0 0 0 0 1
butoxycarbonyl)amino]-5-bromopyridin-3-yl}oxy)ethyl]-4-nitrobenzoate 36 butoxycarbonyl)amino]-5-bromopyridin-3-yl}oxy)ethyl]-4-nitrobenzoate b bu but buto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 )]----)]--(, 12 9 0 0 0 0 1
41.916 mmol) 41.916 4 41 41. 41.9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .)(),(), 8 9 0 0 0 0 1
solution of solution s so sol solu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 (,.,.). 7 8 0 0 0 0 1
suspension was suspension s su sus susp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 , 1 9 0 0 0 0 1
clear. TLC clear. c cl cle clea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 .(/:)-[-(-[ 11 9 0 0 0 0 1
(tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl}oxy)ethyl]-4-nitrobenzoate had (tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl}oxy)ethyl]-4-nitrobenzoate ( (t (te (ter BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 (-)]----)]-- 12 9 0 0 0 0 1
been consumed. been b be bee been BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 ., 2 8 0 0 0 0 1
colourless solution colourless c co col colo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 , 1 9 0 0 0 0 1
white solid white w wh whi whit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 5 .(). 4 9 0 0 0 0 1
The combined the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 5 (),, 4 10 0 0 0 0 1
filtered and filtered f fi fil filt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 -[-(-[(-)]-- 12 9 0 0 0 0 1
bromopyridin-3-yl}oxy)ethyl]-4-nitrobenzoic acid bromopyridin-3-yl}oxy)ethyl]-4-nitrobenzoic b br bro brom BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 --)]--(.,). 11 10 0 0 0 0 1
Di-tert-butyl{5-bromo-3-[1-(2-{[(5-cyano-1-methyl-1H-pyrazol-3-yl) methyl] di-tert-butyl{5-bromo-3-[1-(2-{[(5-cyano-1-methyl-1h-pyrazol-3-yl) D Di Di- Di-t BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 -----[-(-[(-------)] 20 8 0 1 0 0 1
(methyl) carbamoyl}-5-nitrophenyl) (methyl) ( (m (me (met BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 ()--)]--. 9 8 0 1 0 0 1
To a to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 -[-(-[(-)]---- 14 8 0 1 0 0 1
yl}oxy)ethyl]-4-nitrobenzoic acid yl}oxy)ethyl]-4-nitrobenzoic y yl yl} yl}o BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 )]--(.,.)-()-- 14 8 0 1 0 0 1
methyl-1H-pyrazole-5-carbonitrile hydrochloride methyl-1h-pyrazole-5-carbonitrile m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 ----(.,.) 9 8 0 1 0 0 1
2-MeTHF (220 2-methf 2 2- 2-M 2-Me BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 -()(.,) 7 8 0 1 0 0 1
atmosphere. After atmosphere. a at atm atmo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 ., 2 9 0 1 0 0 1
30 min. 30 3 30 30 30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 6 .(.,.,), 8 8 0 1 0 0 1
then the then t th the then BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 .() 3 8 0 1 0 0 1
indicated that indicated i in ind indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 -[-(-[(-)]---- 14 8 0 1 0 0 1
yl}oxy)ethyl]-4-nitrobenzoic acid yl}oxy)ethyl]-4-nitrobenzoic y yl yl} yl}o BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 )]--,. 6 9 0 1 0 0 1
The brown the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 ()(), 5 9 0 1 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 .(), 4 9 0 1 0 0 1
over Na over o ov ove over BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 ,, 2 10 0 1 0 0 1
by silica by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 (//)-- 6 8 0 1 0 0 1
{5-bromo-3-[1-(2-{[(5-cyano-1-methyl-1H-pyrazol-3-yl)methyl](methyl)carba- {5-bromo-3-[1-(2-{[(5-cyano-1-methyl-1H-pyrazol-3-yl)methyl](methyl)carba- {5-bromo-3-[1-(2-{[(5-cyano-1-methyl-1h-pyrazol-3-yl)methyl](methyl)carba- { {5 {5- {5-b BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 ---[-(-[(-------)]()- 21 8 0 1 0 0 1
moyl}-5-nitrophenyl) ethoxy]pyridin-2-yl}imidodicarbonate moyl}-5-nitrophenyl) m mo moy moyl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 --)]--(,) 9 8 0 1 0 0 1
light-yellow solid. light-yellow l li lig ligh BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 -. 2 2 0 1 0 0 1
Di-tert-butyl [3-cyano-2,10,16-trimethyl-12-nitro-15-oxo-10,15,16,17-tetra- di-tert-butyl D Di Di- Di-t BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 7 --[--,,------,,,-- 18 8 0 0 0 0 1
hydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclote- hydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclote- hydro-2h-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclote- h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 --,-()[,-][,,]- 15 7 0 0 0 0 1
tradecin-7-yl]imidodicarbonate 4. tradecin-7-yl]imidodicarbonate t tr tra trad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 --].--- 7 8 0 0 0 0 1
bromo-3-[1-(2-{[(5-cyano-1-methyl-1H-pyrazol-3-yl)methyl](methyl)carbamoyl}- bromo-3-[1-(2-{[(5-cyano-1-methyl-1H-pyrazol-3-yl)methyl](methyl)carbamoyl}- bromo-3-[1-(2-{[(5-cyano-1-methyl-1h-pyrazol-3-yl)methyl](methyl)carbamoyl}- b br bro brom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 --[-(-[(-------)]()- 20 8 0 0 0 0 1
5-nitrophenyl)ethoxy]pyridin-2-yl}imidodicarbonate 11 5-nitrophenyl)ethoxy]pyridin-2-yl}imidodicarbonate 5 5- 5-n 5-ni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 -)]--(.,.), 11 9 0 0 0 0 1
(3.17 g, (3.17 ( (3 (3. (3.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 (.,.),()(,.)(, 14 8 0 0 0 0 1
9.80 mmol) 9.80 9 9. 9.8 9.80 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 .)---(). 8 8 0 0 0 0 1
CataCXiumA (267 catacxiuma C Ca Cat Cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 7 (,..), 6 8 0 0 0 0 1
N 2 n N N N N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 7 no 0 9 0 0 0 0 1
for 16 for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 7 ., 2 9 0 0 0 0 1
formed. The formed. f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 7 .() 3 9 0 0 0 0 1
(3 Â (3 ( (3 (3 (3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 ().(), 6 9 0 0 0 0 1
dried over dried d dr dri drie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 7 ,, 2 10 0 0 0 0 1
with EtOAc with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 7 (),. 4 9 0 0 0 0 1
EtOAc (5 etoac E Et EtO EtOA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 7 ()--[--,,--- 12 9 0 0 0 0 1
nitro-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno) pyrazolo nitro-15-oxo-10,15,16,17-tetrahydro-2h-8,4-(metheno) n ni nit nitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 ---,,,---,-()[,-][,,] 21 9 0 0 0 0 1
benzoxadiazacyclotetradecin-7-yl]imidodicarbonate 4 benzoxadiazacyclotetradecin-7-yl]imidodicarbonate b be ben benz BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 --](.,). 8 9 0 0 0 0 1
7-Amino-2,10,16-trimethyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2H-8, 7-Amino-2,10,16-trimethyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2H-8, 7-amino-2,10,16-trimethyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2h-8, 7 7- 7-A 7-Am BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 --,,------,,,---, 17 7 0 0 0 0 1
4-(metheno)pyrazolo [4,3-h][2,5,11]benzoxadiazacyclotetradecine-3- 4-(metheno)pyrazolo 4 4- 4-( 4-(m BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 -()[,-][,,]-- 13 7 0 0 0 0 1
carbonitrile 5. carbonitrile c ca car carb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 8 .--[--,,-- 10 8 0 0 0 0 1
12-nitro-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo [4,3-h][2,5,11] 12-nitro-15-oxo-10,15,16,17-tetrahydro-2h-8,4-(metheno)pyrazolo 1 12 12- 12-n BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 ----,,,---,-()[,-][,,] 22 8 0 0 0 0 1
benzoxadiazacyclotetradecin-7-yl]imidodicarbonate 4 benzoxadiazacyclotetradecin-7-yl]imidodicarbonate b be ben benz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 --](.,.) 8 8 0 0 0 0 1
(30 ml) (30 ( (3 (30 (30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 ()()/(,). 9 8 0 0 0 0 1
completed, the completed, c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 8 ,- 2 8 0 0 0 0 1
stirred for stirred s st sti stir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 8 ., 2 9 0 0 0 0 1
a further a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 7 8 ()/(,). 7 8 0 0 0 0 1
stirred at stirred s st sti stir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 8 ()/(,) 6 9 0 0 0 0 1
added. The added. a ad add adde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 8 ., 2 8 0 0 0 0 1
showed that showed s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 8 no 0 8 0 0 0 0 1
the desired the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 8 ., 2 8 0 0 0 0 1
with H with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 8 (),. 4 8 0 0 0 0 1
suspension was suspension s su sus susp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 8 . 1 9 0 0 0 0 1
EtOAc until etoac E Et EtO EtOA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 . 1 8 0 0 0 0 1
layer was layer l la lay laye BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 8 ,--,,- 6 9 0 0 0 0 1
trimethyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo trimethyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo trimethyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2h-8,4-(metheno)pyrazolo t tr tri trim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 -----,,,---,-() 15 8 0 0 0 0 1
[4,3-h][2,5,11]benzoxadiazacyclo tetra [4,3-h][2,5,11]benzoxadiazacyclo [ [4 [4, [4,3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 [,-][,,]--(.,) 14 8 0 0 0 0 1
yellow solid. yellow y ye yel yell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 8 .()/.[];(,) 11 8 0 0 0 0 1
d 8.48 d d d d d BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 7 8 .(,.,),.(,.,),.(,),.(,., 24 10 0 0 0 0 1
1 H), 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 8 ),.(,),.(,.,),.(,),.(,., 24 9 0 0 0 0 1
2 H), 2 2 2 2 2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 8 ),.(,),.(,),.(,.,). 19 6 0 0 0 0 1
Separation of separation S Se Sep Sepa BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 ()---,,------,,,- 17 8 0 0 0 0 1
tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclote- tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclote- tetrahydro-2h-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclote- t te tet tetr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 --,-()[,-][,,]- 15 8 0 0 0 0 1
tradecine-3-carbonitrile (R)-5 tradecine-3-carbonitrile t tr tra trad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 --()-()---,,---- 16 8 0 0 0 0 1
15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11] 15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11] 15-oxo-10,15,16,17-tetrahydro-2h-8,4-(metheno)pyrazolo[4,3-h][2,5,11] 1 15 15- 15-o BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 --,,,---,-()[,-][,,] 20 8 0 0 0 0 1
benzoxadiazacyclotetradecine-3-carbonitrile (S)-5. benzoxadiazacyclotetradecine-3-carbonitrile b be ben benz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 --()-.,- 8 8 0 0 0 0 1
protection and protection p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 10 , 1 9 0 0 0 0 1
with the with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 10 , 1 9 0 0 0 0 1
(Supplementary Fig. (supplementary ( (S (Su (Sup BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 10 (.)., 5 9 0 0 0 0 1
4, which 4, 4 4, 4, 4, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 ,-- 3 9 0 0 0 0 1
well as well w we wel well BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 10 .. 2 9 0 0 0 0 1
The analytical the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 no 0 8 0 0 0 0 1
(100 Â (100 ( (1 (10 (100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 (...,),(. 9 9 0 0 0 0 1
DEA) in dea) D DE DEA DEA) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 10 )..(). 6 9 0 0 0 0 1
Rt (Peak rt R Rt Rt Rt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 10 ()..() 6 10 0 0 0 0 1
SFC (Chiralpak sfc S SF SFC SFC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 10 (..,, 5 9 0 0 0 0 1
45% ethanol 45% 4 45 45% 45% BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 .) 2 9 0 0 0 0 1
((R)-5) as ((r)-5) ( (( ((R ((R) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 (()-)(.,,)(()-) 15 9 0 0 0 0 1
solid (6.01 solid s so sol soli BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 10 (.,,). 6 3 0 0 0 0 1
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 8 11 :./ 3 10 0 1 0 0 0
ARTICLE ARTICLE article A AR ART ARTI BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 8 11 no 0 10 0 1 0 0 0
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 8 11 ::./../ 7 10 0 0 0 0 0
9 9 9 9 9 9 9 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 8 11 no 0 10 0 0 0 0 0
(10R)-7-amino-2,10,16-trimethyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2H- (10R)-7-amino-2,10,16-trimethyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2H- (10r)-7-amino-2,10,16-trimethyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2h- ( (1 (10 (10R BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ()---,,------,,,--- 19 8 0 1 0 0 1
8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile 8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile 8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile 8 8, 8,4 8,4- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ,-()[,-][,,]-- 14 8 0 1 0 0 1
(R)-5 (Peak (r)-5 ( (R (R) (R)- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ()-():.()/.[];(, 16 8 0 1 0 0 1
CDCl 3 cdcl C CD CDC CDCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ).(,.,),.(,.,.,),. 18 8 0 1 0 0 1
(d, J (d, ( (d (d, (d, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (,.,),.(,.,),.(,.,),. 21 9 0 1 0 0 1
(q, J (q, ( (q (q, (q, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (,.,),.(,),.(,.,),.(,),. 24 9 0 1 0 0 1
(s, 3 (s, ( (s (s, (s, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (,),.(,.,);(,).,. 17 9 0 1 0 0 1
(d, J (d, ( (d (d, (d, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (,.),.,.,.,.,.(,.),.,., 23 10 0 1 0 0 1
127.40, 123.09, 127.40, 1 12 127 127. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,.,.,.,.,.,.,.,.,.,., 22 9 0 1 0 0 1
22.60. Correlates 22.60. 2 22 22. 22.6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ..()-. 6 6 0 1 0 0 1
(10S)-7-amino-2,10,16-trimethyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2H- (10S)-7-amino-2,10,16-trimethyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2H- (10s)-7-amino-2,10,16-trimethyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2h- ( (1 (10 (10S BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ()---,,------,,,--- 19 8 0 1 0 0 1
8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile 8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile 8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile 8 8, 8,4 8,4- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ,-()[,-][,,]-- 14 8 0 1 0 0 1
(S)-5 (Peak (s)-5 ( (S (S) (S)- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ()-():.()/.[]. 14 6 0 1 0 0 1
The synthesis the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 --[()-----,,--- 15 8 0 1 0 0 1
oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11] oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11] oxo-10,15,16,17-tetrahydro-2h-8,4-(metheno)pyrazolo[4,3-h][2,5,11] o ox oxo oxo- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 -,,,---,-()[,-][,,] 19 7 0 1 0 0 1
benzoxadiazacyclotetradecin-7-yl]imidodicarbonate (R)-6 benzoxadiazacyclotetradecin-7-yl]imidodicarbonate b be ben benz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 --]()-(.) 9 8 0 1 0 0 1
is described is i is is is BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 . 1 2 0 1 0 0 1
Di-tert-butyl [(10R)-3-cyano-2,10,16-trimethyl-12-nitro-15-oxo-10,15,16,17- di-tert-butyl D Di Di- Di-t BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 1 --[()---,,------,,,- 20 7 0 0 0 0 1
tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclote- tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclote- tetrahydro-2h-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclote- t te tet tetr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 --,-()[,-][,,]- 15 7 0 0 0 0 1
tradecin-7-yl]imidodicarbonate (R)-4. tradecin-7-yl]imidodicarbonate t tr tra trad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 --]()-.()---,,-- 16 8 0 0 0 0 1
methyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3- methyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3- methyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2h-8,4-(metheno)pyrazolo[4,3- m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 -----,,,---,-()[,- 18 7 0 0 0 0 1
h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile (R)-5 h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile h h] h][ h][2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 ][,,]--()-(,.), 15 8 0 0 0 0 1
(Boc) 2 (boc) ( (B (Bo (Boc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 ()(.,.)(.,.)() 14 8 0 0 0 0 1
stirred at stirred s st sti stir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 .(/:) 5 8 0 0 0 0 1
material had material m ma mat mate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 .- 2 8 0 0 0 0 1
centrated in centrated c ce cen cent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 ,- 2 8 0 0 0 0 1
matography (CH matography m ma mat mato BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 (/:), 5 8 0 0 0 0 1
(CH 2 (ch ( (C (CH (CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 1 (/:,.)--[()---,,-- 18 8 0 0 0 0 1
methyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3- methyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3- methyl-12-nitro-15-oxo-10,15,16,17-tetrahydro-2h-8,4-(metheno)pyrazolo[4,3- m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 -----,,,---,-()[,- 18 7 0 0 0 0 1
h][2,5,11]benzoxadiazacyclotetradecin-7-yl]imidodicarbonate (R)-4 h][2,5,11]benzoxadiazacyclotetradecin-7-yl]imidodicarbonate h h] h][ h][2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 ][,,]--]()-(,) 14 8 0 0 0 0 1
white solid. white w wh whi whit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 1 .()/.[].(,). 12 8 0 0 0 0 1
(d, J (d, ( (d (d, (d, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 (,.,),.(,.,),.(,.,.,),.(, 25 9 0 0 0 0 1
J ¼ j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 1 .,),.(,.,),.(,.,),.-.(, 23 8 0 0 0 0 1
J ¼ j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 1 .,.,),.(,),.(,),.(,.,),.(, 26 10 0 0 0 0 1
H); 13 h); H H) H); H); BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 1 );(,).,.,.,.,.,., 17 8 0 0 0 0 1
141.92, 141.17, 141.92, 1 14 141 141. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 .,.,.,.,.,.,.,.,.,.,., 22 9 0 0 0 0 1
83.58, 71.94, 83.58, 8 83 83. 83.5 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 .,.,.,.,.,.,.. 14 5 0 0 0 0 1
Di-tert-butyl [(10R)-12-amino-3-cyano-2,10,16-trimethyl-15-oxo-10,15,16,17- di-tert-butyl D Di Di- Di-t BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 3 --[()-----,,----,,,- 20 8 0 0 0 0 1
tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclote- tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclote- tetrahydro-2h-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclote- t te tet tetr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 3 --,-()[,-][,,]- 15 8 0 0 0 0 1
tradecin-7-yl]imidodicarbonate (R)-12. tradecin-7-yl]imidodicarbonate t tr tra trad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 3 --]()-.(, 9 8 0 0 0 0 1
0.947 mmol) 0.947 0 0. 0.9 0.94 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 3 .)(.,.)() 9 8 0 0 0 0 1
dropwise manner dropwise d dr dro drop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 3 --[()---,,-- 12 9 0 0 0 0 1
12-nitro-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11] 12-nitro-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11] 12-nitro-15-oxo-10,15,16,17-tetrahydro-2h-8,4-(metheno)pyrazolo[4,3-h][2,5,11] 1 12 12- 12-n BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 3 ----,,,---,-()[,-][,,] 22 9 0 0 0 0 1
benzoxadiaza cyclotetradecin-7-yl]imidodicarbonate benzoxadiaza b be ben benz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 3 --]()-(,.) 10 8 0 0 0 0 1
in THF in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 3 ()., 4 9 0 0 0 0 1
LCMS showed lcms L LC LCM LCMS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 3 . 1 9 0 0 0 0 1
(165 mg, (165 ( (1 (16 (165 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 3 (,.)(.,.)() 11 8 0 0 0 0 1
again added again a ag aga agai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 . 1 9 0 0 0 0 1
at 20 at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 .(), 4 9 0 0 0 0 1
layer washed layer l la lay laye BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 (), 3 8 0 0 0 0 1
vacuum to vacuum v va vac vacu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 . 1 9 0 0 0 0 1
purified by purified p pu pur puri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 (/:,.)-- 8 9 0 0 0 0 1
[(10R)-12-amino-3-cyano-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8, [(10R)-12-amino-3-cyano-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8, [(10r)-12-amino-3-cyano-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2h-8, [ [( [(1 [(10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 3 [()-----,,----,,,---, 21 8 0 0 0 0 1
4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecin-7-yl] 4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecin-7-yl] 4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecin-7-yl] 4 4- 4-( 4-(m BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 3 -()[,-][,,]--] 14 7 0 0 0 0 1
imidodicarbonate (R)-12 imidodicarbonate i im imi imid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 3 ()-(,).()/. 11 8 0 0 0 0 1
[M þ [m [ [M [M [M BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 3 [];(,).-.(,),.(,),. 19 9 0 0 0 0 1
(d, J (d, ( (d (d, (d, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 3 (,.,),.(,),.-.(,),.-.(,),.-. 28 10 0 0 0 0 1
(m, 1 (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 3 (,),.-.(,),.(,),.(,),.(,.,), 28 10 0 0 0 0 1
1.53 (br 1.53 1 1. 1.5 1.53 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 3 .(,),.(,). 10 3 0 0 0 0 1
Di-tert-butyl [(10R)-3-cyano-12-iodo-2,10,16-trimethyl-15-oxo-10,15,16,17- di-tert-butyl D Di Di- Di-t BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 --[()-----,,----,,,- 20 8 0 0 0 0 1
tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclote- tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclote- tetrahydro-2h-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclote- t te tet tetr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 --,-()[,-][,,]- 15 7 0 0 0 0 1
tradecin-7-yl]imidodicarbonate (R)-6. tradecin-7-yl]imidodicarbonate t tr tra trad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 --]()-.-- 9 8 0 0 0 0 1
[(10R)-12-amino-3-cyano-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H- [(10R)-12-amino-3-cyano-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H- [(10r)-12-amino-3-cyano-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2h- [ [( [(1 [(10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 [()-----,,----,,,--- 20 8 0 0 0 0 1
8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecin-7-yl] 8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecin-7-yl] 8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecin-7-yl] 8 8, 8,4 8,4- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 ,-()[,-][,,]--] 15 7 0 0 0 0 1
imidodicarbonate (R)-12 imidodicarbonate i im imi imid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 ()-(,.)(., 10 8 0 0 0 0 1
0.762 mmol) 0.762 0 0. 0.7 0.76 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .)()(,.). 9 9 0 0 0 0 1
The mixture the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 .(/:) 5 9 0 0 0 0 1
that no that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 . 1 8 0 0 0 0 1
reaction mixture reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 no 0 8 0 0 0 0 1
yellow oil, yellow y ye yel yell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 ,(/:) 5 9 0 0 0 0 1
to give to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 .( 2 8 0 0 0 0 1
di-tert-butyl [(10R)-3-cyano-12-iodo-2,10,16-trimethyl-15-oxo-10,15,16,17- di-tert-butyl d di di- di-t BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 --[()-----,,----,,,- 20 8 0 0 0 0 1
tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecin- tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecin- tetrahydro-2h-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecin- t te tet tetr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 --,-()[,-][,,]- 15 8 0 0 0 0 1
7-yl]imidodicarbonate (R)-6 7-yl]imidodicarbonate 7 7- 7-y 7-yl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 -]()-(,).()/ 12 8 0 0 0 0 1
714.6 [M 714.6 7 71 714 714. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .[];(,).(,,),. 14 8 0 0 0 0 1
(s, 1 (s, ( (s (s, (s, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 (,),.(,.,),.(,),.(,.,),.-. 26 10 0 0 0 0 1
(m, 1 (m, ( (m (m, (m, BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 (,),.-.(,),.(,),.(,),.(,.,), 28 10 0 1 0 0 1
1.50 (s, 1.50 1 1. 1.5 1.50 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 .(,);(,).,.,.,., 16 8 0 1 0 0 1
141.71, 141.17, 141.71, 1 14 141 141. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 .,.,.,.,.,.,.,.,.,., 20 9 0 1 0 0 1
110.07, 96.80, 110.07, 1 11 110 110. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 .,.,.,.,.,.,.,.,.. 18 7 0 1 0 0 1
(R)-19-Amino-13-(7,9-dioxo-6,10-dioxa-8-spiro[4.5]decylideneiodo)-4,8- (R)-19-Amino-13-(7,9-dioxo-6,10-dioxa-8-spiro[4.5]decylideneiodo)-4,8- (r)-19-amino-13-(7,9-dioxo-6,10-dioxa-8-spiro[4.5]decylideneiodo)-4,8- ( (R (R) (R)- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 ()----(,--,---[.])-,- 21 8 0 1 0 0 1
dimethyl-16-methyl-9-oxo-17-oxa-4.5.8.20-tetraazatetracyclo[16.3.1.02, dimethyl-16-methyl-9-oxo-17-oxa-4.5.8.20-tetraazatetracyclo[16.3.1.02, dimethyl-16-methyl-9-oxo-17-oxa-4.5.8.20-tetraazatetracyclo[16.3.1.02, d di dim dime BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 -------...-[..., 16 8 0 1 0 0 1
6.010,15]docosa-1(22),2,5,10(15),11,13,18,20-octaene-3-carbonitrile (R)-13. 6.010,15]docosa-1(22),2,5,10(15),11,13,18,20-octaene-3-carbonitrile 6 6. 6.0 6.01 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 .,]-(),,,(),,,,---()-. 22 8 0 1 0 0 1
To a to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 ()-(.,.) 8 9 0 1 0 0 1
(8 ml), (8 ( (8 (8 (8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 (),()(, 7 8 0 1 0 0 1
0.42 mmol), 0.42 0 0. 0.4 0.42 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 .),(.,.). 9 9 0 1 0 0 1
was stirred was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 no 0 9 0 1 0 0 1
by rotary by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 .() 3 8 0 1 0 0 1
solution of solution s so sol solu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ,-[.]-,-(.,.) 13 9 0 1 0 0 1
aqueous Na aqueous a aq aqu aque BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 (.,.). 6 9 0 1 0 0 1
at room at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ., 2 9 0 1 0 0 1
materials was materials m ma mat mate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 . 1 8 0 1 0 0 1
water (B8 water w wa wat wate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ()(). 5 8 0 1 0 0 1
extracts were extracts e ex ext extr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ,. 2 8 0 1 0 0 1
reaction mixture reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 () 2 8 0 1 0 0 1
yield the yield y yi yie yiel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 (.,.). 6 7 0 1 0 0 1
1 H 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 9 6 :(.,).(,.,),.(,., 17 9 0 1 0 0 1
1 H), 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 9 6 ),.(,.,.,),.(,.,),.(,., 23 10 0 1 0 0 1
1 H), 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 9 6 ),.(,.,),.(,,),.(,,),. 22 9 0 1 0 0 1
(s, J (s, ( (s (s, (s, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 (,,),.-.(,,),.-.(,,),. 22 9 0 1 0 0 1
(s, J (s, ( (s (s, (s, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 (,,)...;:(.,).,.,., 19 9 0 1 0 0 1
148.27, 144.61, 148.27, 1 14 148 148. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 .,.,.,.,.,.,.,.,.,., 20 9 0 1 0 0 1
125.62, 123.13, 125.62, 1 12 125 125. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 .,.,.,.,.,.,.,.,.,.,., 22 9 0 1 0 0 1
37.39, 31.49, 37.39, 3 37 37. 37.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 .,.,.,.,.,.,....;(/)[] 22 8 0 1 0 0 1
calcd. for calcd. c ca cal calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 6 .,..[]. 7 9 0 1 0 0 1
C 39 c C C C C BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 6 ... 3 5 0 1 0 0 1
General method general G Ge Gen Gene BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 .-- 3 8 0 0 0 0 1
synthesis of synthesis s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 [].'' 5 9 0 0 0 0 1
radiofluorination module radiofluorination r ra rad radi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 9 no 0 8 0 0 0 0 1
according to according a ac acc acco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 ., 2 9 0 0 0 0 1
loop were loop l lo loo loop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 ,. 2 9 0 0 0 0 1
methyl iodide methyl m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 no 0 8 0 0 0 0 1
purged through purged p pu pur purg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 . 1 8 0 0 0 0 1
One milligram one O On One One BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 ()- 3 8 0 0 0 0 1
solution prepared solution s so sol solu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 no 0 8 0 0 0 0 1
anhydrous DMF. anhydrous a an anh anhy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 9 . 1 9 0 0 0 0 1
just prior just j ju jus just BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 .. 2 9 0 0 0 0 1
equivalents of equivalents e eq equ equi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 no 0 9 0 0 0 0 1
the amide the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 . 1 9 0 0 0 0 1
11 CO 11 1 11 11 11 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 9 ()(- 4 9 0 0 0 0 1
iodide production iodide i io iod iodi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 9 )-- 3 8 0 0 0 0 1
(B365 mCi) (b365 ( (B (B3 (B36 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 9 () 2 8 0 0 0 0 1
helium. Then, helium. h he hel heli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 .,. 3 9 0 0 0 0 1
Semi-prep purification semi-prep S Se Sem Semi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 9 -.. 3 9 0 0 0 0 1
This trace this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 []()- 5 10 0 0 0 0 1
starting precursor starting s st sta star BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 ()-. 4 2 0 0 0 0 1
Two-step radiosynthesis two-step T Tw Two Two- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 -[].-()- 8 9 0 0 0 0 1
was dissolved was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 no 0 9 0 0 0 0 1
in 1 in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 9 . 1 9 0 0 0 0 1
HPLC loop hplc H HP HPL HPLC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 9 . 1 9 0 0 0 0 1
(1,270 mCi) (1,270 ( (1 (1, (1,2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 9 (,)() 5 9 0 0 0 0 1
was transferred was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 ., 2 9 0 0 0 0 1
methyl iodide methyl m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 . 1 8 0 0 0 0 1
reaction mixture reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 -::. 4 8 0 0 0 0 1
ammonium formate, ammonium a am amm ammo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 9 ,,,,. 5 8 0 0 0 0 1
The labelled the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 no 0 9 0 0 0 0 1
was restricted was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 no 0 9 0 0 0 0 1
reproducible. The reproducible. r re rep repr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 . 1 9 0 0 0 0 1
Red path red R Re Red Red BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 9 9 (.). 4 9 0 0 0 0 1
bulb was bulb b bu bul bulb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 ,, 2 9 0 0 0 0 1
easy conversion easy e ea eas easy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 --- 3 8 0 0 0 0 1
carbon-11-labelling reaction. carbon-11-labelling c ca car carb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 9 --. 3 3 0 0 0 0 1
Prior to prior P Pr Pri Prio BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 ,, 2 8 0 0 0 0 1
energized and energized e en ene ener BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 -,, 3 8 0 0 0 0 1
peak was peak p pe pea peak BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 9 . 1 9 0 0 0 0 1
the hydrolysis the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 (.), 4 8 0 0 0 0 1
containing 0.1 containing c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 .. 2 8 0 0 0 0 1
collected (1.5 collected c co col coll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 (.), 4 9 0 0 0 0 1
observed in observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 .- 2 8 0 0 0 0 1
Supplementary Fig. supplementary S Su Sup Supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 .. 2 2 0 0 0 0 1
The hydrolysis the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 , 1 9 0 0 0 0 1
was transferred was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 . 1 9 0 0 0 0 1
hydroxide (4.5 hydroxide h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 9 (.,),(,)(). 11 9 0 0 0 0 1
acetate was acetate a ac ace acet BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 , 1 8 0 0 0 0 1
ARTICLE ARTICLE article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 9 11 no 0 10 0 1 0 0 0
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 9 11 :./ 3 10 0 1 0 0 0
10 10 10 1 10 10 10 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 11 no 0 10 0 0 0 0 0
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 9 11 ::./../ 7 10 0 0 1 0 0
neutralization of neutralization n ne neu neut BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 no 0 9 0 1 0 0 1
on the on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 -. 2 8 0 1 0 0 1
water for water w wa wat wate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 (). 3 9 0 1 0 0 1
product was product p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 (,,) 4 9 0 1 0 0 1
diluted with diluted d di dil dilu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 (,.). 5 5 0 1 0 0 1
Analysis of analysis A An Ana Anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 8 0 1 0 0 1
trapped on trapped t tr tra trap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 9 0 1 0 0 1
(1 ml) (1 ( (1 (1 (1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ()(,.). 7 8 0 1 0 0 1
Sep-Pak indicated sep-pak S Se Sep Sep- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 -.. 3 8 0 1 0 0 1
Quality control quality Q Qu Qua Qual BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 .. 2 8 0 1 0 0 1
[ 18 [ [ [ [ [ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 0 [].. 4 7 0 1 0 0 1
for [ for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 [](,) 5 9 0 1 0 0 1
18 O-enriched 18 1 18 18 18 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 -.- 3 8 0 1 0 0 1
O-18 water o-18 O O- O-1 O-18 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 -(,) 4 8 0 1 0 0 1
integrated currents integrated i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 [].[] 5 8 0 1 0 0 1
delivered to delivered d de del deli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 --. 3 9 0 1 0 0 1
[ 18 [ [ [ [ [ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 0 []:( 4 9 0 1 0 0 1
example, tetraethylammonium example, e ex exa exam BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ,,)(, 5 8 0 1 0 0 1
v/v 7:3) v/v v v/ v/v v/v BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 /:)() 5 9 0 1 0 0 1
amount of amount a am amo amou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 []--. 5 9 0 1 0 0 1
The vial the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 8 0 1 0 0 1
Drierite column drierite D Dr Dri Drie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ., 2 9 0 1 0 0 1
it was it i it it it BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ,() 3 9 0 1 0 0 1
was resumed was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 9 0 1 0 0 1
three times. three t th thr thre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .. 2 9 0 1 0 0 1
Manual synthesis manual M Ma Man Manu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 9 0 []()-()-. 9 9 0 1 0 0 1
ammonium [ ammonium a am amm ammo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 []([]) 6 9 0 1 0 0 1
procedures using procedures p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ()-(-) 6 8 0 1 0 0 1
15 min. 15 1 15 15 15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 . 1 8 0 1 0 0 1
no significant no n no no no BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 9 0 1 0 0 1
mixture by mixture m mi mix mixt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .[]()- 6 8 0 1 0 0 1
produced. produced. produced. p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 1 0 1 0 0 1
Microfluidic synthesis microfluidic M Mi Mic Micr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 []()-. 6 9 0 1 0 0 1
use of use u us use use BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 9 0 1 0 0 1
reactions with reactions r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 8 0 1 0 0 1
decreased incorporation, decreased d de dec decr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 8 0 1 0 0 1
conventional system. conventional c co con conv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .,()- 5 8 0 1 0 0 1
reaction parameters reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 8 0 1 0 0 1
following the following f fo fol foll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 9 0 1 0 0 1
the Discovery the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 8 0 1 0 0 1
optimal conditions optimal o op opt opti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 () 2 8 0 1 0 0 1
precursor (R)-4 precursor p pr pre prec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ()-(), 6 8 0 1 0 0 1
220 °C, 220 2 22 220 220 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 ,. 2 9 0 1 0 0 1
labelled materials, labelled l la lab labe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ,, 2 8 0 1 0 0 1
100 °C 100 1 10 100 100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 ;, 2 8 0 1 0 0 1
the final the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 4 0 1 0 0 1
However, despite however, H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 ,, 2 9 0 1 0 0 1
over 1%. over o ov ove over BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 9 0 1 0 0 1
conditions by conditions c co con cond BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 8 0 1 0 0 1
carbonate yielded carbonate c ca car carb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ()- 3 9 0 1 0 0 1
(Supplementary Fig. (supplementary ( (S (Su (Sup BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 (.). 4 2 0 1 0 0 1
Manual labelling manual M Ma Man Manu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 9 0 []()-.()-() 11 9 0 1 0 0 1
dissolved in dissolved d di dis diss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ()- 3 8 0 1 0 0 1
[ 18 [ [ [ [ [ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 0 [](-).. 7 9 0 1 0 0 1
reaction mixture reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 (,) 3 9 0 1 0 0 1
reaction heated reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 8 0 1 0 0 1
temperature and temperature t te tem temp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 (, 2 9 0 1 0 0 1
0.8 ml) 0.8 0 0. 0.8 0.8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .)(,.). 7 8 0 1 0 0 1
water (16 water w wa wat wate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ()-, 4 8 0 1 0 0 1
by flushing by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ()().- 6 8 0 1 0 0 1
flushed with flushed f fl flu flus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ()(). 5 9 0 1 0 0 1
Product identity product P Pr Pro Prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 (:: 3 8 0 1 0 0 1
þ 0.1 þ þ þ þ þ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 9 0 .,-) 4 7 0 1 0 0 1
(EtOAc þ (etoac ( (E (Et (EtO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 (;.). 5 7 0 1 0 0 1
radiochemically pure. radiochemically r ra rad radi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 . 1 9 0 1 0 0 1
was isolated was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 9 0 1 0 0 1
before the before b be bef befo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ()-[],-. 8 9 0 1 0 0 1
Using SPE using U Us Usi Usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 ,[]()- 6 10 0 1 0 0 1
sufficient to sufficient s su suf suff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 9 0 1 0 0 1
removed during removed r re rem remo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 -, 2 9 0 1 0 0 1
evidenced by evidenced e ev evi evid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 . 1 4 0 1 0 0 1
Purification of purification P Pu Pur Puri BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ()-.()-() 9 10 0 0 0 0 1
dissolved in dissolved d di dis diss BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ()- 3 9 0 0 0 0 1
[ 18 [ [ [ [ [ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 5 [](.).. 7 10 0 0 0 0 1
mixture was mixture m mi mix mixt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 (). 3 9 0 0 0 0 1
reaction mixture reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 () 2 8 0 0 0 0 1
manually loaded manually m ma man manu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 7 0 0 0 0 1
Semi-Prep column semi-prep S Se Sem Semi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 -:/. 4 8 0 0 0 0 1
ammonium formate. ammonium a am amm ammo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 . 1 8 0 0 0 0 1
flow and flow f fl flo flow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 (). 3 10 0 0 0 0 1
vessel were vessel v ve ves vess BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 - 1 9 0 0 0 0 1
on the on o on on on BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 .() 3 8 0 1 0 0 1
off line. off o of off off BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 .-.. 4 9 0 1 0 0 1
used to used u us use used BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 -.,-- 5 8 0 1 0 0 1
corrected. To corrected. c co cor corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 .-(,) 5 9 0 1 0 0 1
heated at heated h he hea heat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 . 1 8 0 1 0 0 1
neutralized to neutralized n ne neu neut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 (,.) 4 8 0 1 0 0 1
NaOAc (3 naoac N Na NaO NaOA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 (,.). 5 8 0 1 0 0 1
cartridge (3.55 cartridge c ca car cart BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 (.)[]()-() 10 8 0 1 0 0 1
À 3.36 à À À À À BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 6 .(-). 5 7 0 1 0 0 1
purity ¼ purity p pu pur puri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 ;. 2 6 0 1 0 0 1
Automation of automation A Au Aut Auto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 []. 3 9 0 1 0 0 1
the GE the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 ,[],, 5 8 0 1 0 0 1
TracerLab FX tracerlab T Tr Tra Trac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 . 1 8 0 1 0 0 1
HPLC purification hplc H HP HPL HPLC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 ()-, 4 8 0 1 0 0 1
Sep-Pak using sep-pak S Se Sep Sep- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 --.. 4 9 0 1 0 0 1
V-vial was v-vial V V- V-v V-vi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 -(,). 5 9 0 1 0 0 1
reaction was reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 no 0 9 0 1 0 0 1
of a of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 (,.)(,.). 9 8 0 1 0 0 1
the vial the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 (.)[] 5 9 0 1 0 0 1
(R)-1 was (r)-1 ( (R (R) (R)- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 ()-().[]()- 11 9 0 1 0 0 1
1, which 1, 1 1, 1, 1, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 ,. 2 4 0 1 0 0 1
Animal husbandry. animal A An Ani Anim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 . 1 8 0 1 0 0 1
conducted in conducted c co con cond BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 no 0 8 0 1 0 0 1
(IACUC) guidelines (iacuc) ( (I (IA (IAC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 (). 3 8 0 1 0 0 1
PET image pet P PE PET PET BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 10 6 . 1 8 0 1 0 0 1
procedures authorized procedures p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 no 0 8 0 1 0 0 1
Massachusetts. Studies massachusetts. M Ma Mas Mass BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 . 1 8 0 1 0 0 1
(B10 kg (b10 ( (B (B1 (B10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 ().(, 5 8 0 1 0 0 1
intramuscularly) and intramuscularly) i in int intr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 6 ) 1 8 0 1 0 0 1
anaesthesia was anaesthesia a an ana anae BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 (-). 4 8 0 1 0 0 1
A flexible a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 10 6 no 0 8 0 1 0 0 1
radiotracer and radiotracer r ra rad radi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 6 no 0 8 0 1 0 0 1
PET scanner. pet P PE PET PET BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 10 6 . 1 9 0 1 0 0 1
bed positions, bed b be bed bed BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 , 1 8 0 1 0 0 1
subsequent emission subsequent s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 no 0 9 0 1 0 0 1
and spanning and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 .. 2 7 0 1 0 0 1
[ 11 [ [ [ [ [ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 6 [] 2 9 0 1 0 0 1
followed by followed f fo fol foll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 . 1 9 0 1 0 0 1
concurrent with concurrent c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 . 1 9 0 1 0 0 1
acquisition consisted acquisition a ac acq acqu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 ( 1 8 0 1 0 0 1
described above) described d de des desc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 ).- 3 7 0 1 0 0 1
dimensional mode dimensional d di dim dime BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 no 0 9 0 1 0 0 1
180 s 180 1 18 180 180 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 6 . 1 9 0 1 0 0 1
transition between transition t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 , 1 9 0 1 0 0 1
with data with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 :,.,, 5 10 0 1 0 0 1
25.5, 34, 25.5, 2 25 25. 25.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 .,,.,,.,,.. 11 9 0 1 0 0 1
reconstructed on reconstructed r re rec reco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 .. 2 9 0 1 0 0 1
using the using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 ' 1 9 0 1 0 0 1
with corrections with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 ,, 2 9 0 1 0 0 1
deadtime and deadtime d de dea dead BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 6 . 1 8 0 1 0 0 1
decay-corrected to decay-corrected d de dec deca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 - 1 9 0 1 0 0 1
body weight body b bo bod body BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 . 1 8 0 1 0 0 1
animal, with animal, a an ani anim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 ,( 2 9 0 1 0 0 1
Bq/cc) or bq/cc) B Bq Bq/ Bq/c BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 /)(). 5 5 0 1 0 0 1
Data availability. data D Da Dat Data BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 10 . 1 10 0 0 0 0 1
from the from f fr fro from BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 . 1 6 0 0 0 0 1
References References references R Re Ref Refe BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 10 no 0 10 0 0 0 0 1
1. Kelleher, 1. 1 1. 1. 1. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 10 .,..,. 6 9 0 0 0 0 1
importance of importance i im imp impo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 ..., 4 8 0 0 0 0 1
2357-2368 (2010). 2357-2368 2 23 235 2357 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 10 -(). 4 2 0 0 0 0 1
2. Cheuk, 2. 2 2. 2. 2. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 10 .,.,..:() 9 9 0 0 0 0 1
spreads its spreads s sp spr spre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 .,-(). 6 6 0 0 0 0 1
3. Iams, 3. 3 3. 3. 3. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 10 .,..,.. 7 10 0 0 0 0 1
in non-small in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 10 -..,-(). 8 7 0 0 0 0 1
4. Takeoka, 4. 4 4. 4. 4. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 10 .,.,,.,,.,. 11 8 0 0 0 0 1
partners of partners p pa par part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 () 2 8 0 0 0 0 1
anaplastic large anaplastic a an ana anap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 10 , 1 9 0 0 0 0 1
reaction. J. reaction. r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 .....,-(). 10 6 0 0 0 0 1
5. Malik, 5. 5 5. 5. 5. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 10 .,...: 6 9 0 0 0 0 1
treatment of treatment t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 - 1 8 0 0 0 0 1
anaplastic lymphoma anaplastic a an ana anap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 10 ..,-(). 7 9 0 0 0 0 1
6. Johnson, 6. 6 6. 6. 6. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 10 .,...()-----,,-- 16 9 0 0 0 0 1
15-oxo-10,15,16,17-tetrahydro-2H-8,4-(m etheno)pyrazolo[4,3-h][2,5,11]- 15-oxo-10,15,16,17-tetrahydro-2h-8,4-(m 1 15 15- 15-o BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 10 --,,,---,-()[,-][,,]- 21 8 0 0 0 0 1
benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), benzoxadiazacyclotetradecine-3-carbonitrile b be ben benz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 10 --(-), 6 9 0 0 0 0 1
inhibitor of inhibitor i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 10 ()-() 5 9 0 0 0 0 1
with preclinical with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 - 1 8 0 0 0 0 1
ALK-resistant mutations. alk-resistant A AL ALK ALK- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 10 -....,-(). 10 7 0 0 0 0 1
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 :./ 3 10 0 1 0 0 0
ARTICLE ARTICLE article A AR ART ARTI BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 no 0 10 0 1 0 0 0
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 ::./../ 7 10 0 0 0 0 0
11 11 11 1 11 11 11 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 11 no 0 10 0 0 0 0 0
7. D'Arcangelo, 7. 7 7. 7. 7. BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .',.,,..,.. 11 7 0 0 0 0 1
lymphoma kinase lymphoma l ly lym lymp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 no 0 8 0 0 0 0 1
cancer. Curr. cancer. c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ....,-(). 9 5 0 0 0 0 1
8. Ceccon, 8. 8 8. 8. 8. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,... 5 8 0 0 0 0 1
Lung Cancer lung L Lu Lun Lung BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 .,-(). 6 3 0 0 0 0 1
9. Song, 9. 9 9. 9. 9. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.,,.,.: 9 8 0 0 0 0 1
lymphoma kinase lymphoma l ly lym lymp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ()- 3 7 0 0 0 0 1
resistance. Acta resistance. r re res resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ...,-(). 8 5 0 0 0 0 1
10. Costa, 10. 1 10 10. 10. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,..:? 6 8 0 0 0 0 1
Lancet Oncol. lancet L La Lan Lanc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 .,-(). 6 3 0 0 0 0 1
11. Dempke, 11. 1 11 11. 11. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,...- 6 7 0 0 0 0 1
treatment strategy? treatment t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ?.,-(). 7 6 0 0 0 0 1
12. Klempner, 12. 1 12 12. 12. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,..,.. 7 8 0 0 0 0 1
metastases from metastases m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 -: 2 8 0 0 0 0 1
the CNS. the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ....,(). 8 4 0 0 0 0 1
13. Zou, 13. 1 13 13. 13. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,...-,/, 9 8 0 0 0 0 1
first and first f fi fir firs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ., 2 8 0 0 0 0 1
70-81 (2015). 70-81 7 70 70- 70-8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 -(). 4 1 0 0 0 0 1
14. Elleraas, 14. 1 14 14. 14. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.. 4 8 0 0 0 0 1
ALK clinical alk A AL ALK ALK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 (-). 4 7 0 0 0 0 1
Angew. Chem. angew. A An Ang Ange BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 .....,-(). 10 5 0 0 0 0 1
15. Gainor, 15. 1 15 15. 15. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,...-- 7 8 0 0 0 0 1
generation ALK generation g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 -.., 4 8 0 0 0 0 1
1118-1133 (2016). 1118-1133 1 11 111 1118 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 0 -(). 4 1 0 0 0 0 1
16. Iragavarapu, 16. 1 16 16. 16. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,... 5 8 0 0 0 0 1
J. Hematol. j. J J. J. J. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ...,(). 7 3 0 0 0 0 1
17. Shea, 17. 1 17 17. 17. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.,,..,.- 10 8 0 0 0 0 1
cell lung cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 : 1 8 0 0 0 0 1
treatment approaches. treatment t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 .....,-(). 10 7 0 0 0 0 1
18. Sullivan, 18. 1 18 18. 18. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.,.-: 7 8 0 0 0 0 1
latest evidence latest l la lat late BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 .....,-(). 10 7 0 0 0 0 1
19. Toyokawa, 19. 1 19 19. 19. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.,. 5 8 0 0 0 0 1
ALK inhibitors alk A AL ALK ALK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 : 1 7 0 0 0 0 1
preclinical data. preclinical p pr pre prec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ....,-(). 9 6 0 0 0 0 1
20. Yamazaki, 20. 2 20 20. 20. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.. 4 7 0 0 0 0 1
pharmacokinetic-pharmacodynamic relationships pharmacokinetic-pharmacodynamic p ph pha phar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 -: 2 8 0 0 0 0 1
a case a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 11 0 . 1 8 0 0 0 0 1
Drug Metab. drug D Dr Dru Drug BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 ..,-(). 7 4 0 0 0 0 1
21. Zou, 21. 2 21 21. 21. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,...-- 7 8 0 0 0 0 1
ROS1/ALK inhibitor ros1/alk R RO ROS ROS1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 /-. 3 8 0 0 0 0 1
Proc. Natl proc. P Pr Pro Proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ...,-(). 8 5 0 0 0 0 1
22. Bernard-Gauthier, 22. 2 22 22. 22. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .-,.,,..,,.,. 13 9 0 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 11 0 no 0 8 0 0 0 0 1
imaging. Molecules imaging. i im ima imag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 .,-(). 6 4 0 0 0 0 1
23. Hicks, 23. 2 23 23. 23. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,..,,..,,..,,.,. 17 8 0 0 0 0 1
Radiolabeled small radiolabeled R Ra Rad Radi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 no 0 8 0 0 0 0 1
SPECT. Molecules spect. S SP SPE SPEC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 .,-(). 6 4 0 0 0 0 1
24. Holland, 24. 2 24 24. 24. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,..,,.,. 9 8 0 0 0 0 1
in cancer. in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 11 0 ....,-(). 9 5 0 0 0 0 1
25. Holland, 25. 2 25 25. 25. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,..,,.,. 9 8 0 0 0 0 1
enzymes in enzymes e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ......,-(). 11 7 0 0 0 0 1
26. Holland, 26. 2 26 26. 26. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,... 5 9 0 0 0 0 1
Alzheimer's disease: alzheimer's A Al Alz Alzh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ':...., 7 8 0 0 0 0 1
323-331 (2014). 323-331 3 32 323 323- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 -(). 4 1 0 0 0 0 1
27. Liang, 27. 2 27 27. 27. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,...- 6 10 0 0 0 0 1
(PF-04802367) that (pf-04802367) ( (P (PF (PF- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 0 (-): 4 8 0 0 0 0 1
neuroimaging. Angew. neuroimaging. n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ......,-(). 11 6 0 0 0 0 1
28. Costa, 28. 2 28 28. 28. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,... 5 8 0 0 0 0 1
inhibitor crizotinib. inhibitor i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ....,-(). 9 6 0 0 0 0 1
29. Rotstein, 29. 2 29 29. 29. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,..,,..,,.,.. 14 8 0 0 0 0 1
hypervalent iodine(III)-mediated hypervalent h hy hyp hype BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ()-- 4 7 0 0 0 0 1
hindered aromatics. hindered h hi hin hind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ...,(). 7 5 0 0 0 0 1
30. Rotstein, 30. 3 30 30. 30. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,... 5 9 0 0 0 0 1
diverse pharmaceuticals diverse d di div dive BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ()..., 6 8 0 0 0 0 1
4407-4417 (2016). 4407-4417 4 44 440 4407 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 -(). 4 1 0 0 0 0 1
31. Stephenson, 31. 3 31 31. 31. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,...- 6 7 0 0 0 0 1
18F-FPEB and 18f-fpeb 1 18 18F 18F- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 -....,-(). 10 7 0 0 0 0 1
32. Wilson, 32. 3 32 32. 32. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,..,,.,,.,.[]- 15 9 0 0 0 0 1
iodomethane: a iodomethane: i io iod iodo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 :...., 6 8 0 0 0 0 1
529-532 (2000). 529-532 5 52 529 529- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 -(). 4 1 0 0 0 0 1
33. Zoltewicz, 33. 3 33 33. 33. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,..,..-- 9 9 0 0 0 0 1
pyridines. Steric pyridines. p py pyr pyri BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 .....,-(). 10 8 0 0 0 0 1
34. Gomez-Vallejo, 34. 3 34 34. 34. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .-,.,. 6 9 0 0 0 0 1
of high of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 [][]- 5 9 0 0 0 0 1
the combination the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ...., 5 8 0 0 0 0 1
1011-1017 (2011). 1011-1017 1 10 101 1011 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 6 -(). 4 2 0 0 0 0 1
35. Philippe, 35. 3 35 35. 35. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,.. 4 9 0 0 0 0 1
2-(4-N-[ 11 2-(4-n-[ 2 2- 2-( 2-(4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 -(--[])--([]).. 15 8 0 0 0 0 1
Radiat. Isot. radiat. R Ra Rad Radi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ..,-(). 7 4 0 0 0 0 1
36. Bilsland, 36. 3 36 36. 36. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,... 5 10 0 0 0 0 1
in anaplastic in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 11 6 no 0 8 0 0 0 0 1
indications. Neuropsychopharmacology indications. i in ind indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 .,-(). 6 6 0 0 0 0 1
37. Zanotti-Fregonara, 37. 3 37 37. 37. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .-,.,.. 7 9 0 0 0 0 1
safety of safety s sa saf safe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ---..... 8 9 0 0 0 0 1
Mol. Imaging mol. M Mo Mol Mol. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 .,-(). 6 3 0 0 0 0 1
38. Pascali, 38. 3 38 38. 38. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,.. 4 9 0 0 0 0 1
microfluidic reaction microfluidic m mi mic micr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 ...,-(). 8 7 0 0 0 0 1
39. Ungersboeck, 39. 3 39 39. 39. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,..[]- 7 8 0 0 0 0 1
approach. Nucl. approach. a ap app appr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ....,-(). 9 5 0 0 0 0 1
40. Zeng, 40. 4 40 40. 40. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,.., 5 8 0 0 0 0 1
a potent, a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 11 6 ,,-, 4 8 0 0 0 0 1
factor receptor factor f fa fac fact BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ....,- 6 8 0 0 0 0 1
(2015). (2015). (2015). ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 6 (). 3 0 0 0 0 0 1
41. Yudin, 41. 4 41 41. 41. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,..':,, 8 9 0 0 0 0 1
and future and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 '...,-(). 9 6 0 0 0 0 1
Acknowledgements Acknowledgements acknowledgements A Ac Ack Ackn BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 8 no 0 10 0 0 0 0 1
We would we W We We We BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 8 , 1 10 0 0 0 0 1
Medicine and medicine M Me Med Medi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 8 ,, 2 9 0 0 0 0 1
support. We support. s su sup supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 ..... 5 10 0 0 0 0 1
NIH career nih N NI NIH NIH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 8 () 2 9 0 0 0 0 1
and N.V. and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 ..). 4 9 0 0 0 0 1
for support. for f fo for for BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 . 1 1 0 0 0 0 1
Author contributions author A Au Aut Auth BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 9 no 0 10 0 0 0 0 1
T.L.C., N.S., t.l.c., T T. T.L T.L. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 9 ...,..,..,...,.... 18 8 0 0 0 0 1
radiochemistry. M.D.N., radiochemistry. r ra rad radi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 9 ....,...,..,...... 18 8 0 0 0 0 1
imaging and imaging i im ima imag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 9 ...,..,..... 12 9 0 0 0 0 1
design. T.L.C., design. d de des desi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 9 ....,..... 10 10 0 0 0 0 1
authors discussed authors a au aut auth BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 9 . 1 8 0 0 0 0 1
Additional information additional A Ad Add Addi BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 no 0 10 0 0 0 0 1
Supplementary Information supplementary S Su Sup Supp BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 ://../ 6 10 0 0 0 0 1
naturecommunications naturecommunications naturecommunications n na nat natu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 10 no 0 2 0 0 0 0 1
Competing interests: competing C Co Com Comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 :. 2 10 0 0 0 0 1
Reprints and reprints R Re Rep Repr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 ://../ 6 10 0 0 0 0 1
reprintsandpermissions/ reprintsandpermissions/ reprintsandpermissions/ r re rep repr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 10 / 1 2 0 0 0 0 1
How to how H Ho How How BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 :,... 5 10 0 1 0 0 1
11 C 11 1 11 11 11 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 10 /..., 5 9 0 1 0 0 1
doi: 10.1038/ncomms15761 doi: d do doi doi: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 10 :./(). 6 3 0 1 0 0 1
Publisher's note: publisher's P Pu Pub Publ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 10 ': 2 10 0 1 0 0 1
published maps published p pu pub publ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 . 1 5 0 1 0 0 1
Open Access open O Op Ope Open BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 no 0 6 0 1 0 0 1
Attribution 4.0 attribution A At Att Attr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 10 .,,, 4 7 0 1 0 0 1
adaptation, distribution adaptation, a ad ada adap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 ,, 2 9 0 1 0 0 1
appropriate credit appropriate a ap app appr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 (), 3 10 0 1 0 0 1
Commons license, commons C Co Com Comm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 11 10 ,. 2 9 0 1 0 0 1
material in material m ma mat mate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 ', 2 9 0 1 0 0 1
indicated otherwise indicated i in ind indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 . 1 9 0 1 0 0 1
article's Creative article's a ar art arti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 10 ' 1 9 0 1 0 0 1
regulation or regulation r re reg regu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 , 1 9 0 1 0 0 1
the copyright the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 .,://./ 7 9 0 1 0 0 1
licenses/by/4.0/ licenses/by/4.0/ licenses/by/4.0/ l li lic lice BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 10 //./ 4 1 0 1 0 0 1
r The r r r r r BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 11 11 () 2 10 0 0 0 0 1
ARTICLE ARTICLE article A AR ART ARTI BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 no 0 10 0 1 0 0 0
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 :./ 3 10 0 1 0 0 0
12 12 12 1 12 12 12 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 11 no 0 10 0 0 0 0 0
NATURE COMMUNICATIONS nature N NA NAT NATU BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 ::./../ 7 10 0 0 1 0 0

